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ABSTRACT
Host Signaling Response to Adhesion of
Bifidobacterium infantis
by
Reed N. Gann, Master of Science
Utah State University, 2010
Major Professor: Dr. Daryll B. DeWald
Research Director: Dr. Bart C. Weimer
Department: Biology
Investigations of the molecular binding partners of the probiotic bacterium
Bifidobacterium longum subspecies infantis (B. infantis) and the pathogen
Salmonella enterica subspecies enterica serovar Typhimurium LT2 (Salmonella
ser. Typhimurium) found that these two very different bacteria bind gangliosides.
However, these organisms lead to completely different host health outcomes
when present in the gut. B. infantis is the founding microbial population in the
intestinal tract of breast-fed infants. S. typhimurium is the most important foodborne pathogen that results in humans. This study used an in vitro gut epithelial
cell model to examine the host cellular response to adhesion of B. infantis, which
led to an increase in intestinal epithelium survival. This observation led to a
series of experiments to elucidate the pathway for host signaling initiated by
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adherence of B. infantis to the host membrane to explain the increase in host
cell survival. B. infantis adhesion induced significant (q!0.05) differential
expression of 208 host genes. These genes were associated with increased
broad mechanisms of cell survival that included BIRC3, TNFAIP3, and
SERPINB9. We hypothesized that a biochemical link existed between the host
membrane adhesion protein and the increase in cell survival, mediated via AKT.
We tested this hypothesis to demonstrate that B. infantis interaction initiated
signal transduction using G-proteins via phosphorylation of AKT and induced
production of the BIRC3, TNFAIP3, and SERPINB9. This study discovered
adhesion of B. infantis initiated activation of AKT via phosphorylation of both
Ser473 and Thr308, which results in increased cell survival.
(131 pages)

v
ACKNOWLEDGMENTS
This work was supported by the United States Department of Agriculture
grant Functional Genomics in Nature number 080845 without which this research
would not have been possible. I am grateful to my mentor, Dr. Bart C. Weimer,
for his tireless effort towards this project and my development as a scientist. I
want to thank my lab mates for having patience with my endless questions and
for making me a better person. I am grateful to my committee, Dr. Daryll DeWald
and Dr. Joan Hevel, for their expertise and assistance in helping develop my
writing and science. I want to thank the staff and faculty of Utah State
University’s Biology Department for their open doors and eager minds, which
have always inspired me to ask questions and seek answers. I especially want to
thank all the personnel at Utah State University’s Center for Integrated
BioSystems for the friendship, tutelage, and instruction upon which I relied
heavily during my years at Utah State University.
Lastly I want to give special thanks to my wife, Tina, and my family who
have supported me in all I’ve done. Your support has been invaluable.
Reed N. Gann

vi
CONTENTS

Page
ABSTRACT .......................................................................................................... iii
ACKNOWLEDGMENTS ....................................................................................... v
LIST OF TABLES ...............................................................................................viii
LIST OF FIGURES .............................................................................................. ix
ABBREVIATIONS................................................................................................. xi
CHAPTER
I. INTRODUCTION .......................................................................... 1
II. LITERATURE REVIEW ................................................................ 7
Bacterial Adhesion Mechanisms .......................................... 7
Microbes and Host Cell Signaling ...................................... 12
Extra Cellular Matrix, Gangliosides, and Host Signaling ..... 18
Bifidobacteria and Other Probiotics..................................... 23
III. MATERIALS AND METHODS ................................................... 28
Mammalian Cell Culture ...................................................... 28
Bacterial Culture.................................................................. 29
Ganglioside Binding and Real-Time-PCR ........................... 30
RT-PCR Data Analysis for Ganglioside Binding ................. 31
Host Gene Expression ....................................................... 32
Statistical Analysis of Gene Expression Data ..................... 33
Pathway Analysis Using Ingenuity Pathway Analysis ......... 34
Gene Ontology Analysis...................................................... 34
Protein Sample Collection .................................................. 35
Protein Concentration Determination .................................. 35
Cytotoxicity Assay ............................................................... 36
Statistical Analysis of Cytotoxicity Analysis......................... 37
Western Blot Analysis ......................................................... 37
Adhesion Assay................................................................... 40
IV. RESULTS.................................................................................... 43
Epithelial Cytotoxicity .......................................................... 43
Gene Espression Changes During B. infantis Adhesion ..... 46
V. DISCUSSION .............................................................................. 61

vii
VI. SUMMARY ................................................................................. 68
Hypothesis .......................................................................... 68
Objectives............................................................................ 68
Overview of Results ........................................................... 70
Impact of Work ................................................................... 70
Future Work ........................................................................ 71
REFERENCES ................................................................................................... 74
APPENDICES...................................................................................................... 98
A. Complete list of significantly differentially expressed host genes
following adhesion of B. infantis .................................................. 99
B. GO Trees................................................................................... 114
C. GPCR Protein Analysis ........................................................... 116
D. Permission Letter from P. Desai................................................ 118

viii
LIST OF TABLES
Table

Page

1

Classes of adhesins used by pathogenic bacteria...................................... 8

2

Primary antibody selection and application .............................................. 39

3

Significantly enriched GO categories during B. infantis association with
intestinal epithelial cells in vitro................................................................. 48

A.1

Complete list of significantly differentially expressed host genes
following adhesion of B. infantis ............................................................... 99

ix
LIST OF FIGURES
Figure

Page

1

Schematic representation of LPS ............................................................. 11

2

GPCR signaling pathway involving phospholipase C ............................... 14

3

Eukaryotic cell signaling induced by channels and G-proteins ................. 17

4

Host colonization by pathogenic and probiotic bacteria............................ 25

5

Gut epithelial cytotoxicity with addition of B. infantis (BI) and Salmonella
ser. Typhimurium (ST) after 60 min of co-incubation................................ 44

6

B. infantis binding o f mixed gangliosides on glass beads........................ 46

7

GO Tree and Heat Map of Cellular Component; Nucleus during co-culture
incubation time.......................................................................................... 50

8

GO tree and heat map of the Molecular Function category Transcription
Factor Activity during co-culture incubation .............................................. 51

9

GO tree and heat map of molecular function for sequence specific DNABinding activity during co-culture incubation............................................. 52

10

GO tree and heat map of the biological process Negative Regulation of
Apoptosis during co-culture incubation ..................................................... 53

11

Potential surface receptors and signaling pathways................................. 54

12

G-protein coupled receptor signaling activated
by B. infantis adhesion.............................................................................. 56

13

Adhesion assay ........................................................................................ 57

14

Images of western blots probing signaling cascade ................................. 58

15

Proposed model of host reaction to B. infantis adhesion.......................... 69

16

Additions to field resulting from current study ........................................... 72

B.1

GO Tree Molecular Function .................................................................. 114

x
B.2

GO Tree Biological Process........................................................... in pocket

B.3

GO Tree Cellular Component ................................................................. 115

C.1

GPR20 Protein Analysis ......................................................................... 116

C.2

GPR161 Protein Analysis ....................................................................... 117

xi
ABBREVIATIONS
BSA...................................................................................... Bovine serum albumin
C(t).................................................................................... Threshold cycle number
DAG ................................................................................................... diacylglycerol
DMEM...................................... Dubelco modified Eagle minimum essential media
ECM.......................................................................................... Extracellular matrix
FBS........................................................................................... Fetal bovine serum
FDR ........................................................................................ False-discovery rate
GALT .................................................................... Gut-associated lymphatic tissue
GCOS ................................................... GeneChip operating Software (Affymetrix)
GO ................................................................................................... Gene ontology
GPCR ........................................................................... G-protein coupled receptor
IBS ....................................................................................irritable bowel syndrome
IP3 ...........................................................................................inositol triphosphate
IPA ................................................................................Ingenuity pathway analysis
LPS ........................................................................................... Lipopolysaccharide
M-cells .............................................................................................. Microfold cells
MOI ....................................................................................... Multiplicity of infection
MOPS ................................................................3-morpholinopropanesulfonic acid
MRS.............................................................. deMan, Rogosa and Sharpe medium
OD600 .............................................................................. Optical density at 600 nm
qPCR .........................................................Quantitative polymerase chain reaction

xii
PBS................................................................................ Phosphate buffered saline
PIP3 ......................................................................... Phosphoinositol tri-phosphate
PLC............................................................................................... phospholipase C
PVDF ................................................................................... Polyvinylidene fluoride
RMA................................................................................ Robust multichip average
RT-PCR ........................................................ Real-time polymerase chain reaction
SAM ................................................................. Significance analysis of microarray
SDS ....................................................................................Sodium dodecyl sulfate
TBS....................................................................................... Tris base and sodium
TTBS......................................................................Tris base sodium and tween 20
TC ....................................................................................................Total cell count
TES............................ N-(Tris(hydroxymethyl)methyl)-2-aminoethanesulfonic acid
TLR ............................................................................................... Toll-like receptor
VC..................................................................................................Viable cell count

CHAPTER I
INTRODUCTION
The science of microbiology and immunology, among others, owe their
origins to studies investigating the interactions between humans and pathogenic
microbes (135). The bulk of knowledge concerning the molecular interactions
between eukaryotic and prokaryotic organisms is largely restricted to infectious
disease agents and their impact on the human condition. However, throughout
the decades increasing amounts of information about the interactions between
humans and bacteria that do not result in disease is gaining importance with the
rapid increase in discoveries that describe the important contribution of
commensal and probiotic bacteria to human health and chronic disease (53).
The human gastrointestinal tract is home to ~10 times more bacterial cells
than the number of somatic and germs cells in the entire human organism, which
live harmoniously and in some cases provide health benefits to their human host
(129). In contrast, the link between gut microbiota composition, enzymatic
activity, and dynamic nature with human health is being associated with specific
diseases, including arthritis, cancer, and obesity (27, 88, 143). Consequently, the
gut microbiome project, MetaHIT, an international collaboration, was initiated to
define the gut microbial community structure of humans around the world. The
goal of this initiative is that it will define normal and aberrant gut flora in a
concerted effort to adequately describe the links between microbes and the
human condition (38, 53).
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The microbial community structure of this complex ecosystem is
classically divided into parts pathogenic and commensal microbes (61). It is
recognized to contain an extremely complex set of microbe groupings that play
different roles depending on the host condition, immune status, and the results of
interactions between the gut microbiota and the host. More recently, specific
bacteria are being correlated to improved immune system function,
gastrointestinal balance, lower incidence of diarrhea and other specific benefits
that they deliver to the host (117). These so-called probiotic bacteria, which are
defined as organisms that upon consumption yield the host health benefits
beyond simply providing the host with nutrition (94), are now commercially
available in foods that claim to increase gut health, increase regularity of bowel
function by reducing intestinal transit time, and improve immune function. They
have long been advocated by Mechnikov (148) who claimed they could increase
longevity for those who consume fermented milk products containing these
microbes. Unfortunately, until recently the specific and repeatable health benefits
of probiotic microbes were more fiction than reality (6, 12). In the last few years,
molecular interaction studies yielded specific molecules and mechanisms that
probiotic microbes induce in the host during consumption (40, 45, 140, 155).
Considering the vastly different health effects that different bacteria can provide
to a host, more detailed and mechanistic investigations must brought to bear to
determine what underlies the claimed probiotic benefits so that specific traits and
known biology can be directly linked to specific host benefits.
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Like pathogens, probiotic bacteria must associate with the host via
cellular interactions to bring about their beneficial changes (29). Sela et al. (133)
defined an example of these beneficial interactions in the microbial colonization
of human infant guts via selective growth enrichment via consumption of the
complex oligosaccharides found in human breast milk. This leads to a rapid
expansion of B. infantis promoting infant gut colonization by this microbial
population in breast-fed infants (81). This organism contains a specific set of ~20
genes needed to consume the diverse and complex oligosaccharides that are
found in human milk. Presumably, selective growth advantages of B. infantis will
lead to additional adhesion and health modulation in the infant. Consequently,
adhesion is a critical step in host/microbe association. Among other actions,
adhesion enables an intimate connection between two very different cells that
likely initiates molecular signal transduction responses in both cells that leads to
extensive changes to the gut epithelium as well as other tissues depending on
the cognate receptor interactions.
In the mammalian gut there are many different cell types that includes
epithelial cells, as well as gut-associated lymphoid tissue (GALT), Peyer’s
patches, isolated lymphoid follicles, microfold cells (M-cells), dendritic, and
immune cells (B- and T-cells) (42, 104, 106). While an extensive amount is
known about how pathogenic bacteria invade host cells (43, 66, 83, 121, 132)
relatively little is known about the molecules that are used to bind the host cell
that initiates the complex set of interactions used to impart their action to the
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host. Unfortunately, very little is known about how probiotic bacteria associate
with host cells, yet they clearly have a role in gut health through out life.
Eukaryotic cells commonly transduce external signals into communication
mechanisms via protein-protein interactions, small molecules crossing the cell
membrane, and glyco-conjugate interactions (109). Each of these signaling
methods can be activated by the adhesion of a bacterial cell to a host cell (66,
68). Host signal transduction resulting from bacterial adhesion likely evolved from
different and multiple adhesion molecular events and may account for various
phenotypic reactions displayed by the host, which includes well over 100
molecules each of which lead to multiple and interconnecting signaling networks
inside the host cell to change the phenotype. While only a few representative
members of the interaction types have been explored well enough to define the
specific molecules that interact between the two cell types, let alone the different
types of microbes and host cells, these studies are largely focused on
host/pathogen interactions the lead to disease. Due the disease state and the
impact to human health, the molecular interactions of infectious disease agents
has largely focused on invasion and induced cell death (i.e. apoptosis) (43, 77,
113, 121). These studies led to discovery of toll-like receptors, clatherindependant endocytosis, chemokines, and other key host signaling pathways that
explain disease symptoms and the molecular progression of infectious diseases
all with the aim to reduce or mitigate the symptoms (86, 122, 156).
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Recently Desai et al. (31, 32) demonstrated that probiotic and various
pathogenic bacteria bind gangliosides covalently bound to solid glass beads.
These are the same component of the mammalian extra cellular matrix (ECM)
and are binding partners of various molecules and pathogens, including
Salmonella ser. Typhimurium, Salmonella enteridis, Escherichia coli, Clostridium
botulinum neurotoxins (142), Haemophilus influenzae (22) and many viruses
(141). However, this observation leads one to ask many intriguing questions:
•

If two very different bacteria are binding the same component of their host
cells, what accounts for the difference in the host reaction?

•

What changes are induced by probiotic adhesion in the presence of a
pathogen?

•

Can molecular binding events account for claimed health benefits of
probiotic bacteria?

•

What signal transduction routes are changing that lead to a nonpathogenic outcome?

These questions and preliminary data led to the hypothesis that the signaling
events resulting from host cell adhesion of B. infantis induce gene expression
changes associated with longevity and promote cell survival. Describing the
molecular mechanism that results in health benefits for the host is required for
the identification of other potential probiotic bacteria as well as the application of
probiotic microbes as medical treatments for specific diseases (117). Recent
clinical studies report benefit for treatment of irritable bowel syndrome using
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B. infantis (152). As B. infantis is not a pathogen, where nearly all of the
knowledge related to host signaling related to host-microbe interaction lies, there
is little to no molecular mechanistic explanation for the reported benefits.
This study examined the hypothesis by characterizing the host signal
transduction networks induced by adhesion of a known probiotic bacterium,
B. infantis, to gut epithelial cells in vitro. By determining the host gene expression
a potential pathway was determined and subsequently validated using western
blot analysis for protein level increases and phosphorylation changes that lead to
activation of specific transduction pathways to prove the molecular mechanism
leading to decreased cytotoxicity.
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CHAPTER II
LITERATURE REVIEW
Bacterial Adhesion Mechanisms
The varied means that bacteria use to adhere to surfaces in environmental
niches is as diverse as the bacteria themselves. Adhesion to human cells is the
initial necessary step for bacteria to colonize, bind cellular molecules, and leads
to invasion. As such the mechanisms of pathogenesis has been examined in
detail (11, 35, 43).
The structures described in detail that pathogenic bacteria use for
adherence to host cell membranes consist of fimbriae or pili (113), bacterial
lectins (91), flagella (107), and lipopolysaccharides (LPS) (76) (TABLE 1). In all
cases these bacterial structures are defined to bind sugars or complex sugars on
the host. These adherence factors along with all other proteins that are specific
to bacterial adhesion to some extracellular surface are collectively known as
adhesins (77). Specifically, these attachment factors are necessary to help the
bacteria overcome the net negative charge that exists on both the host cell and
the microbial cell (113). Unfortunately, the proteins that are used to mediate other
interactions beyond sugars are yet to be fully described.
Fimbriae or pili are hair-like structures that extend out from the surface of
bacteria. Often found along the edges or tips of the pili are specific proteins that
bind to specific host targets (35). Fimbriae are found in both Gram-positive and

TABLE 1. Classes of adhesins used by pathogenic bacteria.
Adhesin

Structure

Bacterial Function

Fimbriae (pili)

Short hair-like structures,
often hundreds cover
entire surface of organism,
0.5-10 !M in length

Transfer genetic material and
or proteins during conjugation

ECM components, surface
receptors, use glycan (mannose)
to bind

Protein or protein
complexes, located on
bacterial surface, or at
ends of pili and flagella,

None known; only observed in
specific protein-saccharide
interactions; thought to bind
oligosaccharides during
adhesion to surfaces

Saccharides-found on glycolipids,
glycoproteins, or other host
structures. Often specific for
mannose

Long, flexible hair-like
structures, can be
localized to one region,
few in number, up to
15 !M long

Provide motility

Surface receptors, bacterially
excreted proteins, ECM
components, use glycan
(mannose) to bind

Lipid-A base, saccharide
core with O-antigen
terminus. Typically
anchored in cell surface
but can be excreted

Component of Gram-negative
cell wall.

TLR4 & 5, host lectins

Bacterial
Lectins

Flagella

LPS

Host Target
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Gram-negative bacteria, and are separated into different categories or types
based on how the structures are assembled (113). For gram-positive organisms
there are two main classifications - rod-like and flexible (46, 113). In Gramnegative bacteria five types of pili are found: 1) chaperone–usher pili, 2) curli,
3) Type IV pili, 4) Type III secretion needle (part of the Type III secretion system
that delivers effector molecules to invade the host), and 5) Type IV secretion pili.
As noted in the name of some of the pili classes, these structures are not only
used for adhesion, but also for the secretion of proteins and genetic material
during conjugation, as well as motility (46, 70). The adhesion of Salmonella sv
Typhimurium to specific cell types when expressing specific fimbriae is a
prototypical example of how fimbrial structures allow for specific binding between
host and microbe that are tissue specific and regulated by the local environment
(9). In Salmonella infections a fimbrial lectin, SEF17, specifically binds to host
epithelial fibronectin (an ECM glycoprotein) allowing for the bacteria to adhere
and initiate the infection process with the host cell via subsequent endocytosis
mechanisms (80, 82, 105, 118).
Lectins are proteins that specifically bind saccharides (90). Specificity is
sufficiently high so as to discriminate D-glucose-binding and D-mannose, the C-2
epimer of glucose (39). Nearly all organisms express proteins with lectin activity
(91, 93) and are involved in host-host, host-virus, and host-microbe interactions
(91). Lectins are often found as integral parts of other bacterial adhesins, such as
pili, and may account for the adhesive properties of those structures (91). Lectins
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are often large multi-domain protein complexes but the actual carbohydrate
binding activity is usually observed in a single protein sub-unit or domain within
the larger molecular complex (91). The most studied case of lectin mediated
host-microbe interactions is that of host mannose, galabiose, and Nacetylglucosamine binding by lectins produced by E. coli (107, 147). E. coli Ptype fimbriae specifically bind galabiose found in human urinary tract tissue; their
S-type fimbriae bind mannose in human neural tissue, and E. coli K99 fimbriae
bind N-acetylglucosamine found in intestinal cells (147).
Flagella are long, flexible protein structures that are responsible for
bacterial motility. They are also implicated, as in the case of fimbriae, to display
lectin activity, which account for their role in mediating microbial adhesion (35).
Enterotoxigenic E. coli flagella and its adhesion to host cells is the most studied
model with respect to flagellar-mediated adhesion to the gut. In this model, the
bacterium secretes a protein, EtpA, which is bound at the end of the flagella
filament. The flagellar complex bound by EtpA is presented to host that leads to
adhesion between host and microbe (124). Flagellin, the monomeric constituent
of bacterial flagella, has long been known to induce an inflammatory response
via the binding of the host immune receptor TLR5 (51). Due to the fact that
flagella are used primarily for motility and that the mammalian immune system
has ample receptors specific to bacterial flagellin, initially the thought that flagella
also mediated adhesion was somewhat controversial; in that light that a system
that evolved two separate mechanisms for adhesion and motility would seem
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beneficial (43, 98). In support to dual systems, Salmonella spp. secrete
flagellin to specifically elicit an inflammatory response and thereby recruit the
dendritic cells, the cell that contains the Salmonella specifically target (15). It is
no longer in question that flagella mediate glycan-linked adhesion in eukaryotes
(107, 119). Lipopolysaccharides (LPS, aka endotoxin) mediate adhesion
between bacteria and host cells using Toll-Like Receptors (76, 154). LPS is a
component of Gram-negative bacterial cell membrane and also acts as a toxin
when independent of the bacterial cell (115). LPS (Fig. 1) consist of a lipid A
base, which largely contributes to the toxic nature of this molecule, a saccharide
core and an O-antigen terminus (146). LPS elicits a rapid and sever inflammatory
response in healthy mammals, which is initiated by a chemokine signaling
cascade initiated by TLR4, which specifically binds LPS during the infection
process (154).

FIG. 1. Schematic representation of LPS. The lipid base, shown as orange lines,
is often associated with the bacterial cell membrane with the O-antigen, shown
as blue hexagons, pointed away from the bacterial cell. The saccharide core,
shown in red, is often composed of oligosaccharides such as heptose.
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Bacteria evolved many ways to adhere to host cells. Definition of
specific molecules involved in the association and the signal transduction beyond
sugars and glycans is lacking. This area is growing due to the need for new
antibiotics and emergence of multi-drug resistant strains in gut pathogens,
especially Salmonella (19). However, an extensive amount of work is done to
define the host response to bacterial attachment beyond the use of glycosylation
or polysaccharides.
It should be noted that B. infanits is non-motile (23) or produce LPS.
Without these mechanism commonly used by other bacteria to modify host cell
signaling, the question as to how B. infantis modifies host cell signaling remains.
Microbes and Host Cell Signaling
Successful microorganisms respond to external stimuli by producing a
reaction that results in an increased chance of survival, which leads to adaptation
and evolution of specific responses due to multiple environments and conditions.
Multicellular organisms face an extra level of complexity in responding to external
stimuli because it requires that individual cells communicate with the other cells
at distant locations to produce a coordinated response. Additionally, multiple cell
types within the organism produce and respond to many signals simultaneously.
Transmission of the environmental stimulus to the interior of the cell for
communication is known as cell signaling or signal transduction. The
mechanisms of eukaryotic cell signaling have evolved over time into elegant and
complex networks, with multiple levels of sensitivity, specificity, and regulation.
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Despite the diverse means of signal transduction that have evolved there are
some common themes that are used within a network to channel chemical
signals into cellular responses.
There are two main levels of cell signaling - external stimuli mediated by
ligands binding cellular receptors to propagate a signal into the cell and
intercellular communication, which begins with production of molecules that
interact with other cells. These are key to rapid changes in individual cells to
encompass the entire multicellular organism. Communication occurs when a
signal is propagated through the network to the appropriate target molecules so
that a response can be mounted by the cell (110). Once transduced inside the
membrane, signal transduction is further perpetuated by the use of several
strategies that include modification of signaling molecules with sugars,
phosphates, fatty acids, and additional carbon group modification (e.g.
methylation, acetylation). An example of this type of communication (Fig. 2) is the
activation of G-protein coupled receptors (GPCR). Often this interaction is a
combination of a non-specific adhesion factor that brings the organism close to
the cell that is followed by a more specific protein/cell interaction. Viruses use
this strategy to gain entry into host cells (127). In some cases glycolipids (e.g.
gangliosides) are the non-specific binding partner that leads GPCR activation
(99). Another, example is where an enzyme, phospholipase C - a known
bacteria-associated virulence factor, directly activates and transduces virulence
via membrane GPCRs (24). Subsequently, this lipase cleaves PIP3 into two
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additional messenger molecules, IP3 and DAG, both of which cause a series
of additional signaling changes in the cell that lead to transcriptional changes
(20).

FIG. 2. GPCR signaling pathway involving phospholipase C. GPCRs activate
phospholipase C (PLC), which initiates signaling cascades leading to
transcriptional changes and virulence with bacterial adhesion.
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This is the most prototypical GPCR signaling pathway. In this manner an
external stimulus is integrated and results in a signal being perpetuated inside a
cell to cause a specific response attributed to a specific biological event at the
cellular membrane.
The other main level of signaling occurs between cells. Intercellular
signaling can result from the interaction of surface-bound receptors with a
product from another cell type. For example, chemokines and cytokines are
immune-modulating molecules produced by immune cells to recruit additional
cells to a specific location. These molecules are bound by receptors at the
surface of migrating leukocytes that causes these cells to take on new activities
or migrate to a new location via concentration gradients (153). Other examples
include signaling molecules that bind surface receptors, like GPCRs, to modify
cellular transcription (44), or cross the cellular membrane to receptors that lie
within a cell such as nitric oxide (30).
Intercellular signaling can take place over large distances. Many different
types of signaling molecules ranging from small soluble chemicals to large
proteins (e.g. hormones) or fatty acids travel between cells and organs to induce
changes in the organism. These molecules include gases like nitric oxide,
peptides such as insulin (74), small molecules such as Ca2+ ions (74), fatty acids,
and fatty acid derivatives, such as prostaglandins (7), along with many other
examples.
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Another example is cell-to-cell communication mediated by contact and
adhesion via proteins expressed on cell surfaces that initiate signals in
neighboring cells (Fig. 3). Signaling molecules that are bound to cell surfaces are
effective at perpetuating a signal when that cell comes in contact with another
cell that is displaying the appropriate receptor.
The different properties of each signaling molecule allow for greater
diversity of signaling channels, receptor specificity and sensitivity, as well as
means of regulation. The combination of all of these factors allow for a near
limitless variety of signals that a cell can produce and process.
For each signaling molecule there is a receptor that can detect the
presence of the signaling molecule and in some manner perpetuate the signal.
My hypothesis is that B. infantis is acting as a signaling molecule setting off an
undefined signaling cascade leading to improved host health. As Bifidobacterium
spp. do not invade host cells (103), yet do induce changes in host cells we will
examine the largest classes of cell surface receptors (Fig. 3) that are ion
channel-linked receptors, G-protein coupled receptors, and enzyme linked
receptors (1). These receptors are of interest because it has been demonstrated
that bacteria can act as signaling molecules, binding the surface of host cells and
initiating signaling cascades and they are co-receptors for gangliosides (66, 132).

FIG. 3. Eukaryotic cell signaling induced by channels and G-proteins. Panel 1 depicts Intercellular signals are often
internalized using these common surface receptors. Example A depicts an ion channel-linked surface receptor
responding to ligand binding by opening ion specific channels that allows ions to move into or out of a cell (2).
Example B demonstrates a G-protein-linked surface receptors upon ligand binding activate the associated Gprotein. Inactive G-proteins bind GDP. Upon activation the GDP is displaced by GTP, allowing the G-protein to
activate its target enzymes (111). Example C shows an enzyme-linked surface receptor that bind a ligand to
catalyze a reaction that perpetuates an intracellular signal (131). Panel 2 is an example of intercellular signaling
pathway.
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Extra Cellular Matrix, Gangliosides, and Host Signaling
Microbial binding structures have evolved to bind to a variety of host
structures proteins in the extracellular matrix (ECM) (31, 54) and others as
previously mentioned (14, 39, 64, 71, 91, 121). These receptors are often found
as components of or linked to the host cell signaling machinery, and as such
bacteria, and bacterial secreted components, become signaling molecules. It
then becomes of great interest what the host signaling response is to the
adhesion of different bacterial species. With the intense focus on the sugarbinding molecules, exploration and definition of the binding partners between the
bacterium and the host for the other class of molecules is largely unexplored.
As a common site of bacterial adhesion and of special relevance to this
work is the mammalian ECM (123). The ECM is a structure of proteins and
polysaccharide macromolecules that are largely responsible for cell and tissue
differentiation, migration, repair, adhesion and even wound healing (59). The
overall form and function of tissues is largely a result of cellular ECM interactions
(49, 108). Major constituents of the ECM are glycosaminoglycans (largely found
attached to proteins resulting in the formation of proteoglycans (57)), and fibrous
proteins including collagen (69), elastin, fibronectin, laminin, and vitronectin
(136), all of which are highly glycosylated (147). This results in a myriad of
niches, motifs, and structures that are ideal for bacterial adhesion to occur via
fimbriae or other proteins on the bacterial surface (11). This matrix also plays a
key role in processing cellular communication and tissue structure. The ECM
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binds cells to the basement membrane via integrins in the membrane, which is
also involved in cell shape with the intimate association with actin in the
cytoskeleton (128).
Integrins are signaling proteins that are responsible for binding and
responding to stimuli originating in the ECM, and can perpetuate signals between
cells (17, 52, 63) that enable the ECM to facilitate eukaryotic cell signaling events
between the epithelium and the other underlying tissues (128). Some pathogens,
such as Shigella flexneri, some E. coli strains, and some Salmonella serovars
bind integrins to hijack the host signaling mechanisms that perpetuate invasion
and subsequent systemic infection (73). The exact binding domain (glycan or
protein) is not yet defined.
Gangliosides are key components of the host plasma membrane that play
integral roles in signaling (55, 97, 99) and are constructed of a ceramide core
with an attached oligosaccharide (together called a glycosphingolipid) to which
one or more sialic acid is bound (78). These compounds are found in high
concentration in lipid rafts, where interestingly GPCRs are also found to be
concentrated. Maudsley et al. (97) found that when GPCRs are located in lipid
rafts they initiate cell signaling networks that lead to increased cell proliferation.
In other cases in the same cell GPCRs outside of lipid rafts initiate signaling
networks that lead to decreased proliferation. Further links between GPCR
signaling and gangliosides was described by Gouni-Berthold et al. (55) whose
work showed that gangliosides initiated signaling events via GPCR pathways in
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smooth muscle cells. McNamara et al. (99) described how Pseudomonas
aeruginosa flagella bind gangliosides in vitro. Close association of gangliosides
with host cell signaling events, specifically via GPCRs, and the known binding of
gangliosides by B. infantis (31, 32) recently demonstrated by Desai et al. point
one to question. Does B. infantis initiate signaling cascades via GPCRs following
adhesion of gangliosides?
Bacteria modulate host cell signaling during adhesion and invasion (66,
73, 132). Yersinia infections are a classic example of how a pathogenic microbe
affects the signaling mechanisms of a host cell. As reviewed by Isberg et al. (66),
a protein expressed on the surface of Yersinia spp. called invasin is able to bind
multiple integrins that are expressed on the surface of microfold cells (M-cells)
found in Peyer’s patches. These specialized cells are responsible for antigen
sampling in the lumen of the gut and are considered to be the front line of the
mucosal immune system (67). Integrins, the molecular binding partner of invasin,
are responsible not only for cellular adhesion but also initiating intracellular
signaling cascades (17, 52, 63). By specifically binding integrins found on M-cells
Yersinia spp. induce M-cells to phagocytose the bound bacterium by
manipulating the host signaling mechanisms. Subsequently, the internalized
bacteria are hidden within a membrane bound compartment inside the host cell
preventing the organism’s immune system from eliciting a response to eradicate
or clear the infection.
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Another example of cell signaling manipulation by a pathogen is Listeria
monocytogenes gut infections. Similar to many gut pathogens,
L. monocytogenes induces phagocytosis by manipulating the host signaling
mechanisms for the cytoskeleton. This organism uses internalin A and B, which
interacts with E-cadherin on the host membrane to induce cytoskeletal changes
that enables endocytosis and access to the cytosol (132). In the host, E-cadherin
is a key protein that mediates epithelial cell adhesion and tight gap junction
maintenance, but also plays a role in intracellular signaling via the Ecadherin/PKC signaling pathway (79, 87, 145). L. monocytogenes uses this
strategy along with actin movement to move laterally between cells as a method
to evade the immune response so the infection can spread throughout the host.
This strategy is also used to move between cell types. For example, this is how
L. monocytogenes moves from the gut into circulation and then to cross the
blood-brain barrier to cause a secondary infection from the initial invasion site in
the gut epithelium (132).
Commensal bacteria also modulate the host immune system to allow the
host to tolerate their presence (5). Recent findings linked host cell signaling
caused by the presence of commensal bacterial LPS, which is usually only found
on pathogens, and the subsequent decrease in the amount of pro-inflammatory
mediators in vitro (36). Furthermore, factors produced by the host following the
introduction of commensal bacteria initiate differential gene expression in the
host with respect to cell surface receptors that are specific to bacterial surface
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molecules, without which the cells ability to illicit an inflammatory response is
greatly reduced (16). In effect, the commensal microbes prime the immune
system. Additionally, Bacteroides thetaiotaomicron reduces inflammatory
cytokine production by inducing nuclear exportation of RelA via a PPAR-!dependant pathway (72).
As previously mentioned, the vast majority of knowledge with respect to
host microbe interactions is limited to the host-pathogen and host-commensal
relationships (Fig. 3). In a recent review Marteau et al. (95) described many
studies that demonstrated the results of the presence of probiotic microbes on
host health, but noted that the field lacks specific information about the pathways
from which those effects were derived. Even studies that have specifically
addressed an individual probiotic microbe and the effect that specific microbe
has on host health, have not demonstrated the specific mechanism of action,
with respect to host signaling cascade or host-microbe binding partners (89).
One study using B. infantis showed increased phosphorylation of MAPK proteins,
but not the signaling route that led to increased phosphorylation or what
phenotype the modified phosphorylation led to in the cell (40). Additional
information to define the specific events that occur immediately following
probiotic adhesion and the host signaling cascade that is triggered would provide
critical information to provide a sound physiological role for these organisms.
Furthermore this will aid in identification of new probiotic strains, as well as the
implementation of probiotics to treat specific human ailments.
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Bifidobacteria and Other Probiotics
What today are recognized as organisms from the genus Bifidobacterium
were first described by Tissier in 1899-1900 and called Lactobacillus bifidus
(112). The name was largely given due to frequent observation of bifurcating,
gram-positive rod morphology observed in microscopy. Subsequent studies
showed that this bacterium dominated the gut microbiota of breast fed infants
(41, 151). Differences in Bifidobacterium populations depending on the food
source of the infant were observed and studied in the early 20th century starting
with Tissier, and continue to this day (75). Most recently the genome of
B. infantis 15697 revealed genes that allow this bacteria to digest human milk
oligosaccharides that remain indigestible to humans alone that give bifidobacteria
a nutrient-based selective advantage in breast-fed infants (133).
Probiotics are bacterial organisms that when consumed provide some
benefit to the host other than the basic nutrition gained from their consumption
(47). The term “probiotic” was most likely first used by Kollath in 1953 to describe
anything that restored the health of patients suffering from malnutrition; however,
direct association to bacteria came from Vergin slightly later (56). The idea that
bacteria could have beneficial impacts on human health dates back to the Nobel
Laureate, Ilya Ilyich Mechnikov, who later in his life recognized that by
manipulations of the body’s microbiota by diet, the health of an individual could
be influenced, which he quietly associated with benefit (148).
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Recent clinical trials assessing the ability of a B. infantis strain to
remediate the symptoms of irritable bowel syndrome (IBS) revealed that indeed
giving encapsulated B. infantis 35624 to women with IBS significantly reduced
their symptoms versus a placebo (152). This result most certainly classifies
B. infantis spp. as a probiotic organism. While the beneficial aspects of these
bacteria are known, the mechanisms by which these benefits are gained remain
unclear (Fig. 4).
Numerical dominance of B. infantis in the infant gut of breast fed babies is
well known (41, 75, 151). This near complete occupation of host gut at such a
critical time in the organism’s development strongly suggests an extended
evolutionary history between the two organisms. If both organisms did not
experience some positive influence towards their survival such a relationship
would be selected against. This idea is further bolstered by the work of Sela et al.
(133) showing that B. infantis contains genes that allow the bacteria to digest
complex oligosaccharides found in human milk that are not able to be digested
by human cells. While this could be the driving selective pressure that maintains
this near symbiosis in infants, the mechanisms within the host that permit the
bacterial presence, as well as the observations of improved health in adults, are
not explained by Sela’s observations.
Competitive exclusion of bacterial pathogens is often cited as the
mechanism by which adult hosts gain benefits, as studies with other probiotics
have demonstrated (85). Other groups found that certain B. infantis species
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secrete soluble antimicrobial compound(s) that lead to the death of bacterial
pathogens in vitro (89).

FIG. 4. Host colonization by pathogenic and probiotic bacteria.
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While these observations may be contributing factors they completely ignore
the most important step necessary for bacterial access to the gut surface for
adhesion, colonization, and persistence. As previously described, bacteria can
initiate signaling pathways and following adhesion to host cells elicit host
signaling cascades that are ultimately responsible for the final host phenotype
(66, 132). Recognizing the likely evolutionary history that should exist between
host and microbe in the case of B. infantis one would expect to find specific
receptors that are the molecular binding partners of the bacteria. Consequently,
one can expect that adhesion of B. infantis will initiate a cell-signaling cascade
within the host.
The prevailing theory is that B. infantis competitively excludes other
bacteria from adhering thus hindering pathogenic infections (89). While this
certainly may play a role in the health benefits it is unlikely to be the complete
story, and does not account for the claimed systemic health benefits that the
microbes impart to the host.
Recent work by Desai et al. (32) demonstrated that food-borne pathogens
and B. infantis bound various components of the ECM (31), suggesting that B.
infantis may initiate signaling via ECM binding. Considering the evolutionary
association and clinical demonstration of B. infantis with the host, it is logical that
adhesion of B. infantis to the host cell invokes the host cell to change. It is very
likely that this is done using known signal transduction routes that initiate new
phenotypes to provide very specific benefits to the host. The lack of knowledge
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surrounding the molecular mechanisms waits to be explored and defined.
Creating an experimental model that allows direct, hypothesis-driven queries of
the cell signaling pathways activated by B. infantis adhesion will provide great
insight into the underlying mechanisms of improved host health could be
uncovered. This would be a step to provide insight into host health as a whole, as
well as a model for uncovering similar information about other microbial/gut
interactions beyond those defined by infectious disease models.
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CHAPTER III
MATERIALS AND METHODS
Mammalian Cell culture
Human colon colorectal adenocarcinoma Caco-2 cells (ATCC HTB-37)
were grown in Dulbecco's modified Eagle's medium (DMEM) high glucose media
with 2 mM L-glutamine and 1 mM sodium pyruvate, combined with %16.6 fetal
bovine serum (FBS) by volume, 10 IU/ml Penicillin, 0.10 mg/ml Streptomycin and
1X non-essential amino acids (EmbryoMax ES Cell Qualified MEM, 100X,
Millipore, Billerica, MA) in accordance with ATCC (American Type Culture
Collection, Manassas, VA) recommendations. Due to the fact that these cells
were to be co-cultured with bacterial cells an additional buffer composed of 10
mM 3-morpholinopropanesulfonic acid (MOPS), 15 mM HEPES, 10 mM N(Tris(hydroxymethyl)methyl)-2-aminoethanesulfonic acid (TES), 2 mM sodium
phosphate was added to further buffer the media (pH 7.2) (37). Incubation
conditions were 37°C at 5% CO2 in a humidified atmosphere. Cells were given
fresh media according to need, but approximately every 2 d. Cells were grown in
BD Falcon T-75 0.2 µm vented-cap, canted-neck flasks (Becton, Dickinson and
Company, Franklin Lakes, NJ). During periods of extended culturing Caco-2 cells
differentiate and exhibit a phenotype similar to that of intestinal epithelial cells.
Time until differentiation is 16 d following confluence (126); to more closely mimic
the conditions found in the human gut all adherence and gene expression assays
will be done at day 21-22 post inoculation to allow for complete differentiation.
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Final feedings 24 hr prior to the addition of bacteria were done with media
lacking antibiotics and serum. This serum starvation was done to promote cell
cycle synchronicity.
Bacterial Culture
B. infantis (ATCC 15697) was sub-cultured twice from freezer stocks to
late stationary phase (36 hours) in deMan, Rogosa and Sharpe broth (MRS)
containing an additional 0.5 % cysteine (Difco, Detroit, MI) at 37ºC using
anaerobic conditions. The cells were centrifuged at a 5,500 X g for 1 min. to
create a loose cell pellet after which the pellet was washed once with PBS and
resuspended in mammalian cell culture media without serum (see above) at the
required density of 10 X 106 CFU/ml (colony forming units). This cell suspension
was used to interact with Caco-2 monolayers at a multiplicity of infection (MOI) of
1000:1 (1000 bacterial cells per Caco-2 cell) (120), which was approximately 10
ml of the afore mentioned cell suspension per T-75 flask.
Salmonella ser. Typhimurium LT2 (ATCC 700720) was grown, from
freezer stocks, in Nutrient Broth (Difco, Detroit, MI) at 37ºC shaking at 220 rpm.
After the first growth phase the cells were collected by centrifugation and
transferred into Nutrient Broth for an additional 24 hr. The third transfer, used to
perform the experiments in this study, was done in cell culture media lacking
serum and antibiotics. After the third transfer, the organisms were grown for
approximately 16 h (stationary phase). These cells were then collected by
centrifugation and re-suspended in fresh cell culture media lacking serum and
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antibiotics at the required density of 1 X 10 CFU/ml). These cells were
subsequently used to conduct adhesion studies with Caco-2 cells at an MOI of
1000:1 (bacterial cell:host cell) in a final volume of 10 ml/flask.
Ganglioside Binding and Real Time-PCR
Gangliosides were purified from bovine buttermilk as described by Walsh
and Nam (149). Briefly, the purification of gangliosides included ultrafiltration of
fresh buttermilk (Gossner Foods, Logan, UT) with a 1 kDa membrane to remove
the lactose followed by an organic extraction with chloroform:methanol:water
(40:80:30). The purified gangliosides (6 !g) were used for immobilization with
100 g of 3 mm solid glass beads (Fisher Scientific, St. Louis, MO), which
produced bioactive beads (gangliobeads) with a mixture of gangliosides on the
surface as described by Walsh and Nam (149).
B. infantis was grown to exponential phase in media and conditions as
described above. Bacterial cells were washed twice in saline and diluted to an
OD600 of 0.2 in saline. This suspension (2 ml) was exposed to 10 beads for 10
min at 25˚C with agitation and washed three times with 50 mM Tris Cl (pH 7.2)
for 5 min each. The presence or absence of B. infantis on the beads was
quantified by RT-PCR (real-time-PCR) using universal bacterial 16S primers
(IDT, Coralville, IA)
Following interaction with B. infantis, beads were washed in saline and
added to 100 !l of distilled water and boiled 10 min to lyse bound bacterial cells.
An aliquot of the boiled sample (12.5 !l) was used for RT-PCR with universal
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bacterial 16S primers (IDT, Coralville, IA). Forward primer sequence was 5’AGAGTTTGATCCTGGCTCAG-3’ and reverse primer sequence was 5’ACGGCTACCTTGTTACGACTT-3’. The DyNAmo HS SYBR Green qPCR Kit
(MJ Research, Waltham, MA) was used as per the manufacturer’s
recommendations in combination with a DNA Engine Opticon 2 thermal cycler
(MJ Research). The thermal cycler was run for 50 cycles of 15 sec at 95˚C
(melting), 30 sec at 60˚C (annealing) and 45 sec at 72˚C (extension and plate
read). The threshold cycle number, C(t), was reported using the Opticon Monitor
analysis software (Ver 2.02, MJ Research). Appropriate negative controls to
probe for nonspecific binding (using 3 mm glass beads instead of gangliobeads)
and sterility of the beads and buffers (using gangliobeads with saline instead of
bacterial suspension) were also performed along with the test samples. The
experiment was done in three biological replicates with RT-PCR in duplicates.
RT-PCR Data Analysis for Ganglioside Binding
A standard curve correlating log CFU with C(t) value was generated, by
performing RT-PCR on samples of DNA extracted from log 5, 6,7 and 8 CFU/mL.
Trend line analysis (performed in Microsoft Excel 2008 V12.0, Redland, WA) of
the resulting C(t) values yielded the Equation (1):
C(t) = 2.624(bacterial population) - 40.77 [r2=0.97]

(Equation 1)

C(t) values obtained from RT-PCR of the ganglioside-containing beads
and glass beads and converted into bacterial population amounts using the
equation generated from the standard curve. These values were then tested for
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significance using an unpaired Student’s t-test to compare the number of
B. infantis adhered to the beads vs. the glass bead control. Statistical analysis
was done using Prism 5.0 (GraphPad Software, San Diego, CA)
Host Gene Expression
Human Caco-2 cells were grown to confluence and allowed to differentiate
following previously established protocols. Bacterial cultures were added at a
MOI of 1000:1. At 30 min, 60 min and 120 min, respectively. Subsequently, 10 ml
of Trizol LS (25), (Invitrogen, Carlsbad, CA) was added to the cell culture flask
and incubated at 37°C for 15 min. Caco-2 cells were more thoroughly lysed by
repeated pipetting of the Trizol LS followed by transfer to 15 ml conical and
stored at -70°C until further RNA purification was done.
Trizol LS containing samples were freeze thawed three times (liquid
N2/60ºC) to further lyse host cells. The samples were then centrifuged at 8,000
rpm for 5 min to pellet cellular debris as well as bacteria that remain intact
following Trizol LS treatment. The supernatant contained Caco-2 RNA. RNA
isolation proceeded as per Trizol LS manufactures’ protocol. RNA quantity was
determined using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific
Inc. Waltham, MA). Sample quality was assessed using the Bio-Rad Experion
RNA StdSens analysis kit with their Experion automated electrophoresis station
(Bio-Rad Laboratories, Hercules, CA).
Two biological replicate RNA samples were subjected to Affymetrix
GeneChip One-Cycle Eukaryotic Target Labeling procedure according to
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manufactures' recommendations. Briefly, sample RNA is reverse transcribed
using T7 oligo (14) primer to create cDNA. This cDNA is again reverse
transcribed using a T7 RNA polymerase, biotinylated nucleotide analogs and
ribonucleotides to create labeled cRNA. These cRNAs were hybridized to a
Human U133+2.0 Affymetrix GeneChip and further processed by the Genomics
Core facilities at the Center for Integrated BioSystems Genomics Core (Utah
State University). The arrays were processed using a GeneChip fluidics station
450, a GeneChip hybridization oven 640 and scanned with a GeneChip Scanner
3000 implementing Affymetrixs’ GeneChip operating software (GCOS).
Statistical Analysis of Gene Expression Data
Using BioConductor (50) via a web based interface (http://cibxcluster.biotec.usu.edu/BioC.html) the raw hybridization intensities from the
arrays were pre-processed using the robust multi-array average (RMA) method
(65). Following pre-processing the data were analyzed using the SAM
(significance analysis of microarrays) plug-in for Microsoft Excel (144) to identify
genes that were significantly differentially expressed with a false discovery rate
(FDR) of less than 5%. The model used was a two-class unpaired time course,
using the default settings. These significant genes were uploaded to Ingenuity
Pathway Analysis (IPA) (116), (Ingenuity Systems Inc., Redwood City, CA) for
pathway reconstruction and visualization.
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Pathway Analysis Using Ingenuity Pathway Analysis
A core analysis using IPA (116) was done using the log2 ratios of
treatments to control for the significant genes identified using SAM. Using the
IPA library, each of the canonical signaling pathways was examined to determine
what pathways contained genes from our dataset. The data set was overlaid onto
the canonical pathways using the “overlay” feature. When protein complexes or
groups of proteins were represented in a pathway, and found to contain a
significantly changing gene, the “show members/membership” feature was used
to identify what specific gene identified by the gene expression analysis was
accounting for significance and what role that gene played in the complex or
protein group. To create pathways for better visualization and for placement in
the text of this document, relevant sections of canonical pathways were selected
and edited in the “pathway designer” portal. All connections between proteins,
small molecules, chemical reactions, etc., are linked to peer reviewed studies
held in the Ingenuity database (use of this feature is available upon subscription
only). Critical links relevant to this study have been cited in this work.
Gene Ontology Analysis
The list of significant genes (log2 ratio) were uploaded to GOEAST (157),
a web based gene enrichment testing tool based on the gene ontology
consortium (4) classification scheme, to determine what groups of molecular
functions, biological processes or cellular components had higher than expected
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significantly differentially expressed genes. Default settings were used with the
exception of the significant level of enrichment, which was set at q" 0.01.
Protein Sample Collection
Co-cultures from which proteins were sampled were created in the exact
same conditions as previously described for the gene expression samples
through the incubation periods with the bacteria. Following interaction with the
respective bacterial treatment, media in flasks was removed and cell layers were
washed with PBS to remove non-adherent bacteria and cellular debris. The cocultures were scraped from the flask and re-suspended in 1 mL cell lysis cocktail
modified from Pawson et al. (109) in 30 mM HEPES (pH 7.4) containing 1 mM
EDTA, 50 mM Sodium pyrophosphate, 100 mM sodium fluoride, 10 mM
orthovanadate, and Roche protease inhibitor cocktail tablet (added fresh, per
manufactures recommendations - 1 tablet per 50mL buffer) (Roche Indianapolis,
IN). The cell suspension and lysis buffer were then added to 2 mL screw cap
tubes with 0.5 g of 0.1 mm glass beads and bead beat in a BioSpec mini-bead
beater (BioSpec Products, Bartlesville, OK) for 30 seconds. The samples were
stored at -80°C for further analysis.
Protein Concentration Determination
Protein concentrations were determined using the Bio-Rad DC Protein
Assay kit according to the manufactures’ protocol, with the exception of using
Bovine Serum Albumin (BSA; catalog number 15561-020) from Invitrogen in

36
place of the provided protein standard. The assay was performed in a Nunc
F96 MicroWell plate using a Molecular Devices SpectraMax Plus 384 plate
reader. Analysis of the readings was done using Molecular Devices SoftMax Pro
software (version 3.1.2). All standard and sample concentrations were quantified
in duplicate.
Cytotoxicity Assay
To assess the impact of the presence of B. infantis to the viability of the
host model, a cytotoxicity assay was performed. Caco-2 cells and bacterial cells
were all cultured as previously described, except that Caco-2 cells were cultured
in 12-well plates instead of flasks. Bacteria were added to the differentiated
Caco-2 monolayers according to the scheme presented in Fig. 4. Following the
120 min. incubation, monolayers with microbes were washed with PBS to
remove non-adherent bacteria, and treated with 1X porcine trypsin for 5-7 min.
Adding fresh cell culture media containing serum and buffer without antibiotics
stopped trypsinization. This suspension was divided in half, and used for analysis
of total cell count and viable cell count using a NucleoCounter (ChemoMetec A/S
Denmark) according to the manufacture recommendations. Briefly, for total cell
counts (TC), 100 µl of lysis buffer followed by 100 µl of fixing buffer to 100 µl of
cell suspensions and briefly mixed using a vortex. For suspensions to assay
viable cell count (VC) 100 µl of suspension was combined with 200 µl PBS and
mixed. Each treatment was measured in using two biological replications.
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Statistical Analysis of Cytotoxicity Assay Data
Cell counts obtained in the cytotoxicity assay were converted into percent
survival using Equation 2:

Percent viable cells = ((TC-VC)/(TC))*100

(Equation 2)

TC = total cell count, VC = viable cell count. Statistical analysis was done using
JMP V7.0 (SAS Institute Inc., Cary, NC). A Tukey’s post hoc analysis was done
to determine the statistical differences between the levels within a treatment.
Western Blot Analysis
The sample loading dye and preparation buffer consisted of 37.5 mM Tris
(pH 6.8) containing 137.5 mM glycerol, 73.75 mM SDS, 1.15 M "mercaptoethanol to reduce disulfide bonds in the proteins, and a few grains of
brilliant blue dye to act as a marker of sample migration. Protein samples at a
concentration of 50 mg/mL were added to the sample dye and preparation buffer
and denatured by boiling for 5 min. Protein samples were then loaded in 10%
Tris-HCl (pH 6.8) polyacrylimide gels and run in the Bio-Rad Mini-PROTEAN 3
cell using a buffer containing 25 mM Tris base (pH 10.7), 192 mM glycine and
3.5 mM SDS (pH 8.3) at 110 V until the dye front had reached the bottom of the
gel. The standard used was MagicMark XP western protein standard from
Invitrogen. The separated proteins were transferred to a PVDF membrane
(Thermo Scientific product number 88518) using a transfer buffer consisting of 25
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mM Tris base (pH 10.7) containing 200 mM glycine and 20% (v/v) methanol in
water. The transfer was done using 100 V for 70 min. After transfer the blot was
probed for the presence of specific proteins corresponding to the potential
signaling pathway determined using the gene expression data using commercial
antibodies (TABLE 2). Western blots were done using the Pierce Fast Western
Blot Kit, according to the manufactures recommendations, with an additional 60
min blocking step with 2% non-fat dry milk in 20 mM Tris base (pH 10.7), 0.5 M
NaCl (TBS), immediately before adding the primary antibody solution.
If cross-reactivity was present that interfered with band development using the
rapid method the analysis was repeated using a classical method (137). The
classical method used a membrane blocked with 2% non-fat dry milk (Wal-mart
Stores Inc., Bentonville AR) in TBS buffer (pH 10.7) for 60 min. The blocking
buffer was removed and the blot was washed with the primary antibody overnight
at 4ºC. The primary antibody was re-suspended in a buffer containing 2% non-fat
dry milk, 20 mM Tris base (pH 10.7), 0.5 M NaCl and 1 mM Tween 20 (TTBS
buffer). Following overnight mixing the blot was washed 2X for 10 min with TTBS
(pH 10.7) buffer without non-fat dry milk and the washes were discarded. The
blot was incubated at room temperature with the secondary antibody solution for
120 min. The secondary antibody solution contained suspended a secondary
antibody, conjugated to horseradish peroxidase, in TTBS buffer (pH 10.7) with
2% non-fat dry milk.
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TABLE 2. Primary antibodies used in this study. All antibodies were purchased
from Novus Biologicals (Littleton, CO) except "-actin, which was purchased from
Sigma-Aldrich (St. Louis, MO). Antibodies targeted toward specific
phosphorylation states of the proteins that correlate to active signaling states are
designated as phospho- and the target’s known phosphorylation site.

Antigen

Species and Type

Dilution or concentration used

GPR20

Rabbit Polyclonal

2 µg/ml

GPR161

Rabbit Polyclonal

2 µg/ml

PYK2

Rabbit Polyclonal

1:500

PYK2 phospho-Tyr402

Rabbit Polyclonal

1:1000

PDK1

Rabbit Polyclonal

2 µg/ml

PDK1 phospho-Ser241

Rabbit Polyclonal

2 µg/ml

AKT1

Rabbit Polyclonal

1:2000

AKT1 phospho-Thr308

Rabbit Monoclonal

1:10000

AKT1 phospho-Ser473

Rabbit Monoclonal

1:10000

TNFAIP3 (A20)

Mouse Monoclonal

2 µg/ml

BIRC3 (aka cIAP2)

Rabbit Polyclonal

1:2000

SERPINB9

Mouse Polyclonal

1:500

"-actin

Mouse Monoclonal

1:10,000
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Following mixing the antibody solution was discarded and the blot was washed
5X for 10 min. in TTBS (pH 10.7) without non-fat dry milk. The blot was protein
side up on plastic wrap, exposed to the western blotting detection reagent
(Amersham ECL Plus) so as to cover the membrane completely, and incubated
for 1 min. Subsequently, the blots were imaged using the chemiluminescent
detection with a FujiFilm LAS-3000 imaging system V 2.0 (FujiFilm U.S.A. Inc,
Valhalla, NY) on the highest setting for 5 min. Image files were analyzed using
FujiFilm Multi Gauge software to detect the bands. To validate constant sample
concentration, blots were stripped and re-probed for "-actin (26). Stripping was
done in a solution containing 62.5 mM Tris base (pH 6.8) containing 69.5 mM
SDS and 100 mM "-Mercaptoethanol, at 50ºC for 20 min. Stripped membranes
were briefly washed in TBS (pH 10.7) without non-fat dry milk followed by sterile
water for 5 min. The membranes were probed as previously described using the
Pierce Fast Western protocol with the previously described additional blocking
step.
Adhesion Assay
Caco-2 cells were cultured as described above and plated at a density of
105 / cm2 in a 96 well plate. Following differentiation, media from the caco-2 cells
was removed and the cells were incubated for one hour at 37°C (5% CO2) in
50 !l of GPR161 or GPR20 antibody serially diluted in DMEM. After 1 h, 50 !l of
bacterial suspension washed in PBS (pH 7.4) and resuspended in the DMEM at
108 CFU/ml was added to the caco-2 cells for an MOI of 100:1 and incubated for
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an additional hour. The non-adherent bacteria were removed via aspiration
and the caco-2 cells were washed three times with 200 !l of 1X Tyrode’s buffer
(140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 10 mM
glucose, 10 mM sodium pyruvate (pH 7.4)). The caco-2 cells were exposed to
50 !l of DNA extraction buffer (AEX Chemunex, France). The cells were
incubated at 37°C for 15 minutes and then at 95°C for 15 min. The cell lysates
were stored at -70°C.
Quantitative PCR (qPCR) was used to quantify the number of adherent
microbes to caco-2 cells. Primer pairs for the desired microbes and caco-2
monolayer were designed using Primer-BLAST (125). Primers used to quantify
B. infantis amplified the fructose-6-phosphate phosphoketolase gene
(BLON_1722) (Forward-GAC AGA GCG TAA CCC AGC TC, Reverse- ACT ACC
CCT GGC CTG AAC TT). Primers used to quantify Caco-2 cells amplified
G3PDH gene (Forward-ACC ACA GTC CAT GCC ATC AC, Reverse- TCC ACC
ACC CTG TTG CTG TA). qPCR was done using iQ SYBR Green qPCR mix (Bio
rad, Hercules, CA) as per the manufacturer’s recommendations using a CFX-96
Real-Time PCR detection system (Bio rad, Hercules, CA). Standard curves with
known number of bacteria (determined by plate count) and know number of
Caco-2 cells (determined by direct microscopic count) were generated (data not
shown). Based on the standard curve the number of bacteria present per caco-2
cell were determined. The results were plotted and error bars added to the plots
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using the standard error of the mean of the 4 observations made per treatment
class.
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CHAPTER IV
RESULTS ..
While the current field of host/microbe relationships is quickly expanding,
little is known about host/probiotic microbe relationship. At the same time use of
probiotic bacteria in food products is increasing with increasingly broad and
undefined health claims, most of which remain to be substantiated. In
consideration of the use of B. infantis and it’s role in the infant gut this study was
undertaken to determine the biological importance, molecular mechanisms and
resulting cellular phenotype induced in vitro by the interaction between an human
intestinal epithelial model and B. infantis. Using a systems biology approach, the
resulting host reaction to B. infantis was characterized as well as the signals
responsible for producing the host phenotype to test the hypothesis that B.
infantis binds host GPCRs to induce new and beneficial activities.
Epithelial Cytotoxicity
The cytotoxicity of gut epithelial cells was assayed to determine if host cell
survival was impacted by adhesion of bacterial cells. Adhesion of B. infantis in
vitro to gut epithelial cells significantly (p=0.006) increased the viable cell
population. Unfortunately, addition of B. infantis simultaneously with Salmonella
ser. Typhimurium did not rescue the host cell from death (Fig. 5). While
B. infantis did not rescue Salmonella ser. Typhimurium–induced cytotoxicity, it
did increase epithelial survival when presented alone. Consequently, the
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remaining experiments focused on the interaction between the host and
B. infantis to define mechanisms that increased survival of gut epithelial cells.
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104

B

Survival (%)

102
100
98

A

96

C

94

C

92
90
88
Control

B. infantis

S. typhimirium

BI:ST (1:1)

Bacterial treatment

FIG. 5. Gut epithelial cytotoxicity with addition of B. infantis (BI) and Salmonella
er. Typhimurium (ST) after 60 min of co-incubation. The organisms were added
at equal concentrations to the cell culture (1:1). Bars with the different letters
indicate significantly difference responses (p<0.05).

Considering the decreased cytotoxicity imparted by B. infantis, the
question becomes how does it impart this effect since this organism is not
invasive, but does adhere to the epithelium? No receptors for B. infantis
adhesion to host cells are known. Consequently, further experiments tested the
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hypothesis that B. infantis bound specific host protein receptors that directly
transduced intracellular signal transduction pathways to increase cell survival.
Without knowledge of a specific receptor we used gene expression regulation
during B. infantis adhesion to uncover the underlying molecular changes in the
membrane proteins that are known to trigger or modify the cell cycle and survival.
To begin glycolipid adhesion was done based on the observations of
Desai et al. (31), to establish a link between gangliosides and cell signaling as
others have demonstrated with other microbes (3, 97, 99). Significantly (p<0.001)
more B. infantis cells were bound to the beads by 10-fold as compared to the
control. (Fig. 6A). Gangliosides are commonly used by viruses and bacteria to
gain entry into the host cell (141, 142). Consequently, B. infantis was added to
the gut epithelia to demonstrate that the microbes also bound GM1 (Fig. 6B) to
determine if this interaction is relevant in vitro. Blocking the GM1 receptor on
caco-2 cells significantly (p=0.05) reduced B. infantis adhesion by ~10%.
Together, these observations indicate that this probiotic microbe uses
gangliosides during adherance to gut cells. It is unlikely that this is the only
receptor used. Subsequently, gene expression was used to discover additional
receptor proteins that may be used by B. infantis to induce signal transduction
pathways that are linked to decreased cytotoxicity.
Gangliosides are directly linked to host signal transduction through
GPCRs (55, 97, 99).
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FIG. 6. B. infantis binding of mixed gangliosides on glass beads. (panel A) and to
caco-2 cells with before and after blocking GM1 with antibody (panel B). In each
panel the treatments containing different letters indicate significant differences
between the treatment and control (p"0.05).

The observations of B. infantis increasing cell longevity and binding
gangliosides suggests that signaling is initiated following adhesion that results in
increased cell survival initiated via GPRC signaling. Therefore, the hypothesis
that B. infantis interacts with host GPCRs during adhesion to decrease
cytotoxicity was tested.
Gene Expression Changes During B. infantis Adhesion
Adhesion of B. infantis to intestinal epithelial cells initiated significant
(q<0.05) regulation of 208 genes in caco-2 cells over 120 minutes co-incubation,
which is ~0.4% of the entire the host genome (TABLE A.1). Gene regulation was
almost entirely induction that increased over incubation time, indicating that the
longer association of this non-invasive microbe initiated gene expression
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changes that led to increasingly pervasive changes in the host cell. The
phenotypic changes observed (Fig. 1) occurred within 120 min; therefore, the set
of genes differentially expressed within the 210 genes mediated increased
survival. B. infantis does not invade the host (103). Consequently, cellular
changes must be transduced via membrane receptors during B. infantis
adhesion.
Considering that the set of induced genes were involved in very diverse
cellular processes and functions, gene ontology (4) (GO) enrichment analysis
(21) was done to highlight the functional associations based on the significantly
differentially expressed genes and reduced cytotoxicity. Significantly enriched
categories were found in each of the three functional GO categories (TABLE 3).
Significant GO nodes contained between 2 and 70 genes within each node.
Based on the specific relationship to cell death, categories were selected for
further investigation to define the molecular mechanism(s) that increased cell
survival (Figs. B.1-B.3).
Critical examination of the GO enrichment analysis to specifically examined
categories associated with decreased host cytotoxicity were identified . The only
significant GO term in cellular component category was “nucleus,” GO:004066
(p=3.24 x 10-5), representing the gene expression regulation via new transcription
factors. Additional examination of genes from this category (Fig. 7) showed that
genes were induced at 60 min. and they remained induced at 120 min. This
temporal pattern was observed in other GO categories as well.

TABLE 3. Significantly enriched GO categories during B. infantis association with intestinal epithelial cells in vitro. Some
genes occur in multiple nodes, so the total number of genes in the analysis do not sum to 210.

Annotation

Number of
molecules in
category out of 210

GO Term

p-value

0043066

nucleus

70

3.24 x 10-05

Biological Process

0006350
0006915
0030198
0043066
0043124
0042994
0006355
0060056
0001843
0006954
0006935
0007567

transcription
apoptosis
extracellular matrix organization
negative regulation of apoptosis
negative regulation of I-kappaB kinase/NF-kappaB
cytoplasmic sequestering of transcription factors
regulation of transcription, DNA-dependent
mammary gland involution
neural tube closure
inflammatory response
chemotaxis
parturition

42
15
5
12
2
2
46
3
3
10
7
2

6.39 x 10-6
1.90 x 10-4
1.67 x 10-4
1.11 x 10-5
4.14 x 10-4
2.26 x 10-4
3.10 x 10-6
7.93 x 10-8
1.23 x 10-4
1.23 x 10-4
1.75 x 10-4
5.19 x 10-4

Molecular Function

0003700
0008140
0008009
0005523
0017022
0004887
0043565

transcription factor activity
cAMP response element binding protein binding
chemokine activity
tropomyosin binding
myosin binding
thyroid hormone receptor activity
sequence specific DNA binding

33
3
4
3
3
2
20

5.29 x 10-10
2.60 x 10-6
1.45 x 10-4
1.23 x 10-4
3.86 x 10-4
8.82 x 10-4
2.78 x 10-7
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GO Category
Cellular
Component
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Additionally, significantly enriched molecular functions were “transcription
factor activity” GO:0003700 (p=5.29 x 10-10) and “sequence specific DNAbinding” GO:0043565 (p=2.78 x 10-7). Further examination of these categories
provided a list of over enriched transcription factors responsible for the
transcription of the genes involved in the host response (Fig. 8-9). Finally, the
biological process GO category contained significantly enriched genes in
“negative regulation of apoptosis” (GO:0043066) (p=1.1 x 10-5), with 12 of the
210 (5.7%) of the total significantly regulated genes in this node. Examination of
this category found genes induced with increasing time at 60 min and 120 min
adhesion of B. infantis that are directly related to the observed phenotype of the
epithelial cell (Fig. 10). As such, mechanisms of the enriched apoptotic genes
were visualized using signal transduction pathways to discern possible routes
that explain the phenotype.
To determine which network and signal cascade molecules were related,
the list of significantly regulated genes analyzed as a set of pathways that
mediate apoptosis with particular attention to networks related to GPCRs and
gangliosides. In total, these analyses pointed to a set of genes associated with
GPCRs and AKT signaling, which is a central regulatory molecule in many signal
transduction pathways, including cell survival, and associated specific signaling
molecules with cell surface receptors (Fig. 11). Overlaying the host gene
expression data during B. infantis association found GPCRs and NF-!B to be
regulated.
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FIG. 7. GO Tree and Heat Map of Cellular Component; Nucleus during co-culture
incubation. Multiple genes are listed as the gene chip contains multiple probesets
for the same gene. The complete GO tree for cellular component is presented in
Fig B.3.
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FIG. 8 GO tree and heat map of the Molecular Function category Transcription
Factor Activity during co-culture incubation. Multiple genes are listed as the gene
chip contains multiple probe sets for the same gene. The complete GO tree for
molecular function is presented in Fig. B.1
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FIG. 9. GO tree and heat map of molecular function for sequence specific DNABinding activity during co-culture incubation. Multiple genes are listed as the
gene chip contains multiple probe sets for the same gene. The complete GO tree
for molecular function is presented in Fig. B.1.
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FIG. 10. GO tree and heat map of the biological process Negative Regulation of
Apoptosis during co-culture incubation. The complete GO tree for biological
process is presented in Fig. B.2.

FIG. 11. Potential surface receptors and signaling pathways. Red fill indicates significant (q<0.05) induction of gene
expression resulting from B. infantis association. Shading of the fill indicates the intensity of increase in regulation.
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However, AKT gene expression was unchanged. NF-!B is a transcription
factor and was implicated as involved in the transcription of the negative
regulation of apoptosis genes during GO enrichment (Fig. 11).
Considering the direct signal transduction link between AKT and NF-!B a
more focused analysis was done to more clearly define the specific interactions
with membrane initiated induction as the beginning point (Fig. 12). Two GPCRs
were induced, and tied with the increased expression of three genes GO analysis
associated with the negative regulation of apoptosis. The induction of membrane
bound cell signaling receptors by the presences of B. infantis lead to the
hypothesis that GPR20 and GPR161 were the receptors bound by B. infantis
adhesion to initiate AKT-mediated signaling to reduce cytotoxicity. To determine
if these proteins were involved in host-microbe binding, an adhesion assay was
done after blocking GPR161 and GPR20 with specific antibodies. Blocking
GPR161 and GPR20 did not significantly (p>0.05) change the number of
adherent bacteria adhered to the cell membrane, indicating that these two
proteins are not acting as the binding site for B. infantis (Fig. 13). These
observations eliminated GPR20 and GPR161 as adhesion partners for B.
infantis, their role in the host-microbe relationship is still unknown, as are their
potential to activate signaling cascades in the host cell. While GM1 was a
receptor for B. infantis, the protein interaction remained unclear. Consequently,
confirmation of AKT was pursued by measuring the protein level and activation
state (i.e. phosphorylation) of specific signaling molecules up and down stream of
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AKT were done to define the signaling network between the membrane and
NF-!B.

FIG. 12. G-protein coupled receptor signaling induced by B. infantis adhesion.
Red fill shading indicates the intensity of gene expression induction during
B. infantis in vitro association with gut epithelium. Red fill indicates significant
(q<0.05) induction of gene expression resulting from B. infantis association.
Shading of the fill indicates the intensity of increase in regulation.
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Fig. 13. Adhesion assay. Blocking of GPR161 and GPR20 did not decrease B.
infantis binding, demonstrating they are not the receptors for adhesion.

Despite the unknown role of GPR20 and GPR161 (58, 96) and being ruled
out as a receptor for B. infantis confirmation of the protein change was evaluated.
The amount of GPR20 protein did not significantly change with B. infantis
treatment over time. However, GPR161 protein content did increase with
treatment and increased slightly over adhesion time (Fig. 14).
Transduction between GPCRs occurs via an adaptor protein (G!q) with
PYK2. The protein level and phosphorylation status remained constant between
treatments and with time of PYK2. Since the protein was constitutively
phosphorylated, it suggests that GPCRs were constantly triggering activation due
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FIG. 14. Images of western blots probing signaling cascade. Protein samples
used in this experiment were total protein samples.
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to established link between GPCRs to PYK2 (34). Unfortunately, the exact
remains to be defined. However, it does indicate that membrane mediation via
PYK2 is involved in B. infantis adhesion. Subsequently, examination of the
protein level and phosphorylation status of PDK1, the next protein involved in
AKT-mediate signaling was examined. The protein level of PDK1 remained
constant during time and B. infantis treatment, as indicated with gene expression.
However, phosphorylation of PDK1 at Ser241 increased with addition of B.
infantis, suggesting that activation of PDK1 kinase activity (18) and subsequent
phosphorylation of AKT (8, 100).
AKT, PKY2, and PDK1 are activated by phosphorylation, which enables
the signaling cascade to progress (48, 130, 134). AKT1 protein concentration
remained constant in the control and B. infantis treated cells. The host had a
small amount of phosphorylation at Ser473 that decreased with time. In contrast,
the phosphorylation status, and thereby activation status, of AKT increased at
Ser473 and Thr308 with the addition of B. infantis (Fig. 14). Phosphorylation at
both sites decreased with time. Thr308 phosphorylation of AKT was only
observed in the B. infantis treated cells indicating that the bacterial adhesion led
to full and complete activation of AKT. Without phosphorylation at Thr308 AKT
activity is greatly reduced nearly to the point of loss of function, and as such
phosphorylation at Thr308 is considered a master regulator for AKT activity
(100).
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The gene expression results indicated induction of BIRC3 (cIAP2),
TNFAIP3 (A20) and SERPINB9. SERPINB9 protein levels were not affected by
B. infantis adhesion (Fig. 14), while both BIRC3 (cIAP2) and TNFAIP3 (A20)
showed increased protein levels in the B. infantis treated cells at all time points.
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CHAPTER IV
DISCUSSION…
Adhesion of B. infantis to a host gut epithelial model significantly
increased the survivability of the host cells. Although when B. infantis was mixed
with Salmonella enterica ser. Typhimurium and added to the host cells a similar
increase in cell survival was not observed. This indicates that B. infantis may
protect host cells rather than rescue them from some challenge. Similar
observations have been made with the probiotic Lactobacillus rhamnosus,
another purported probiotic, when caco2 cells were treated with the probiotic and
then challenged with Salmonella ser. Typhimurium (13). The authors did not
show data or discuss if the host cells treated with L. rhamnosus showed
decreased cytotoxicity, however. Contrary to these findings, Lee Do et al. (84)
found that Bifidobacterium adolescentis, another probiotic microbe, generated
peptidoglycan structures that inhibited caco2 cell growth in a dose dependent
manner, while yet another study with B. adolescentis showed no increase
influence to cell survivability in bacterial treated cells as compared to the control
(45). Literature reports of specific molecular explanations of probiotic/host
interactions contain conflicting and confusing reports. Consequently, this study
sought to provide orthogonal methods of confirmation to prove specific molecular
interactions and signaling routes.
Results from this study demonstrated an increased cell survival.
Considering that contradictory results between B. infantis and B. adolescentis
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treatment, it is likely that this trait is strain dependent. This strain difference
points out the desperate need for genome sequencing and genetically defined
models for understanding the molecular mechanisms underlying the complex
host-microbe relationship as was done in this study. With the disparity of
cytotoxic effects of other probiotics, it can reasonably be concluded that the
increased host cell survival that is observed in B. infantis treated cells may not be
novel, but certainly is significant as it has not been observed with other
probiotics. Increased cell survival could be the underlying mechanism to the
overall improvement in host health observed in humans harboring this probiotic.
It was found that B. infantis bound gangliosides. Gangliosides are
glycolipids with a complex set of structures involved in lipid rafts (3) and are
linked to neurological function. The terminal residue is often sialic acid (147).
During viral and bacterial adhesion they are commonly used as a non-specific
binding partner that enables close association that allows subsequent specific
protein association for invasion (141, 142). They are also directly linked with
triggering cellular signaling cascades (55, 97, 99). This result further encourages
investigation of the host gene expression.
GO enrichment analysis of gene expression data generated from host
cells treated with B. infantis revealed the biological process “negative regulation
of apoptosis” to be significantly over-represented. Molecular function and cellular
component GO results indicated that large transcriptional changes occurred as a
result of B. infantis adhesion.
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Numerous other studies discussed the impact probiotics have on
intestinal epithelial cell health and, attribute those effects to prevention of
pathogenic adhesion, improved cell barrier function, absorption and metabolism
of bacterial toxins, and the production of anti-microbial peptides (6, 12). However,
these studies do not show that probiotics can actually increase cell survival as
was indicated by this gene expression study and cytotoxicity assay.
Western blot analysis of the proteins implicated by the gene expression
and GO enrichments to play a role in altering host cell survival revealed a likely
mechanism by which the increase in survival was observed. Perhaps the most
significant observation from this work is the complete activation of AKT.
Substrate binding and increased rate of enymatic atalysis by AKT requires both
Ser473 and Thr308 phosphorylation to occur with phosphorylation at Ser473
often preceding and usually being a necessary pre-condition of phosphorylation
at Thr308 (100, 130). Only in the B. infantis treated cells are both of the
activation sites for AKT seen as phosphorylated leading to complete activation of
the kinase.
Pathway analysis showed that AKT activation is related to the translation
of three proteins with ties to increased cell survival (10, 62, 138, 139). Three
proteins - cIAP2 (BIRC3), TNFAIP3 (A20) and SERPINB9 - were all induced in B.
infantis treated cells, and not in the other cell treatments, with the exception
being SERPINB9 as it was found in the control cells. These proteins are
downstream of NF-KB and known inhibitors of caspases that are needed for
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apoptosis (28, 33). Induction of these genes and proteins to block caspase
activity is one explanation of increased cell survival with addition of B. infantis.
Other studies of probiotic interactions with host cells have queried AKT
activation as well, but did not query AKT for complete activation. Yan et al. (155)
showed that L. rhamnosus-treated cells led to the phosphorylation of AKT at
Ser473. It was previously mentioned that for complete activation of AKT and
subsequent signaling activity, AKT must be phosphorylated at both Ser473 and
Thr308. Without being completely phosphorylated the ability of AKT to activate
NF-KB and initiate NF-KB’s subsequent effect on host transcription is greatly
reduced. Yan et al. did not test this and so conclusions about whether or not L.
rhamnosus can fully activate AKT cannot be reached.
In light of the data from this work it is likely that activation of AKT and the
subsequent translation of cell survival proteins would be observed in other
probiotic systems. As previously mentioned, other studies attribute the increase
in cell survival observed in probiotic treated cells to some of the other actions
probiotics are observed to render to the host. No other study specifically
postulated that the actual adherence of the probiotic to the host cell set off
signaling cascades increasing host cell survival as has been demonstrated in this
study.
The observed increase in protein concentration of proteins with known ties
to increased cell survival a more complete picture of improved host health can be
formed. In addition to likely excluding pathogenic bacteria from gaining access to
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host cells, B. infantis adhesion increased the host cell survival rate, as well as
responsible for producing anti-microbial compounds known to kill pathogens. The
sum total of the production of anti-microbial compounds, physically excluding
pathogenic bacteria, increasing production of cell survival proteins and
suppression of inflammation is most likely results in the improved health
observed in clinical trials and animal studies.
The implications of the identification of two GPCRs identified as involved
in the signaling resulting in the increased cell survival of the host are unclear.
Gene expression analysis shows these two receptors as potentially involved,
while western blot analysis confirms the presence of these two receptors.
GPR161 and GPR20 are both non-sensory, orphan GPCRs (58, 96). Orphan
receptors are categorized as such because they do not have any known ligands
(96). Very little work has been published on these two receptors. This study is the
first to identify two GPCRs as potentially involved in the manifestation of the
health benefits of probiotics.
Bioinformatic examination of the two receptors’ protein sequences using a
transmembrane region predictor (60, 101, 102) and an N-glycosylation predictor
(114) reveals two potential sites for N-linked glycosylation to occur (Figs. C.1C.2). N-linked glycans are post-translational modifications that result in the
covalent bonding of complex oligosaccharides to asparagine residues in proteins.
These glycans have a basic core structure Man3GlcNAc2Asn (147), followed by
various other terminal sugars, including sialic acid. As previously discussed,
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these carbohydrates are excellent binding partners for bacteria (11).
Gangliosides are also often terminally modified with sialic acids (147), which
have already been shown to be bound by B. infantis. The fact that both of these
glycans share terminal sialic acids as a characteristic could provide a link
between ganglioside binding and the implied involvement of these GPCRs in the
adhesion of B. infants and subsequent cell signaling events that followed. The
relationship between glycans, specifically human milk oligosaccharides, and B.
infantis has been investigated demonstrating that carbohydrates are key binding
structures for these bacteria and play a critical role in their metabolism and
population establishment (92). Identification of these two cell-signaling surface
receptors and their subsequent potential extra-cellular glycosylation sites point
strongly that these two proteins may be the binding partners of B. infantis.
Furthermore, even if these two proteins prove not to be the actual binding
partners but instead the carbohydrates are, an entire group of known signaling
proteins that do not have known ligands are now suspect as binding partners for
not only B. infantis but other bacteria as well. While presence of these GPCRs is
observed in the host cell, the exact sub cellular location of these receptors in this
cell line is unknown. Also, while the total amount of GPR20 remains fairly
constant across treatment levels and time, GPR161 is only observed in the B.
infantis treated cells. This could indicate that while initially bound to gangliosides,
which are concentrated on GPCRs, B. infants then binds GPR20 which then acts
as the primary receptor initiating the signaling cascade, resulting in increased
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expression of GPR161. As there is no known ligand for GPR161, it is possible
that B. infantis adhesion induces the expression of this protein with the express
purpose of using it to further establish itself on the host cellular surface. As the
gut epithelial cells have basolateral and apical surfaces, to be the binding partner
of the bacteria the proteins must be expressed on the apical surface. Further
investigation of these signaling proteins as to their potential as binding partners
of B. infantis while very likely, and was therefore tested with additional
experimentation. The results form these experiments showed that neither of
these induced GPCRs was the binding site of B. infantis (Fig. 13).
In conclusion, this study demonstrated that adhesion of B. infantis to gut
epithelial cells induced significantly higher survival as compared to control cells.
Further investigation as to the underlying mechanisms behind this increase
survival revealed that gangliosides are used for adhesion, while no protein was
identified, in spite induction of two orphan g-protein coupled receptors. Signals
transduced via PYK2 to AKT and ultimately to three anti-apoptotic factors. In
total, B. infantis reduced cytotoxicity via AKT activation with dual
phosphorylation.

68
CHAPTER V
SUMMARY

Hypothesis:
Mammalian signal transduction via GPCR signaling instigated by adhesion
of pathogenic bacteria leads to host cell signaling related to apoptosis, while of
probiotic bacteria induces host cell signaling related to cell proliferation.
Objectives:
1. Adhere probiotic (Bifidobacterium infantis) and pathogenic (Salmonella
ser. Typhimurium LT2) microbes to Caco2 intestinal cells and measure the
gene expression of the signal transduction molecules.
2. Conduct bioinformatic analysis of the gene expression changes to
indentify the specific molecules for the associated with g-protein signaling.
3. Candidate molecules will be verified using Western blot analysis. No more
than 10 proteins will be verified in this objective.
Analysis of the gene expression data as well as the protein expression
data demonstrated conclusively that indeed B. infantis adhesion leads to a
drastically different cellular signal than cells adhered to Salmonella ser.
Typhimirium. However, the data did not show that B. infantis adhesion resulted in
proliferation, but instead an increase in cell survival (Fig. 15). It was seen that gprotein coupled receptors were involved in the host cell signaling. In addition to
the original objectives, all of which were performed as described, a cytotoxicity
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FIG. 15. Proposed model of host reaction to B. infantis adhesion. As determined by the data gathered in this experiment, this proposed model shows what effect adhesion of B. infantis has on a
host epithelial cell. Following adhesion and interaction with some unknown receptor, PYK2 is phosphorylated, leading to the subsequent activation of, also by phosphorylation, PDK1 and AKT.
NFKB is the translocated to the nucleus where it is responsible for the induction of the proteins BIRC3 and TNFAIP3. These two proteins have been shown to decrease cell death (10, 28, 150). Via
an undetermined pathway the orphan G-protein coupled receptor GPR161 is also induced, as indicated by the red fill, and expressed by the host cell. The significance of the expression of this
receptor is not known, although it does not at as the receptor for B. infantis adhesion. According to western blot data, the phosphorylation cascade initiated by B. infantis adhesion has occurred
within 30 minutes post adhesion and by 120 minutes post adhesion the levels of phosphorylated AKT have dropped. Production of BIRC3, TNFAIP3 and GPR161 were all observed within 30
minutes
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assay and ganglioside adhesion assay were performed to understand the
underlying mechanisms responsible for the induction of the survival genes.
These additional studies shed much needed light on this study. Due to the lack
of evidence from the gene expression correlating with cell proliferation, as well as
the decreased cytotoxicity that was observed, the original hypothesis was set
aside and a pursuit of the signals responsible for the decreased cytotoxicity was
undertaken. We were successful in uncovering proteins responsible for the
increase in cell survival and the signals perpetuated resulting in the increased
translation of those proteins.
Overview of Results
A human epithelial model, when adhered to by a known probiotic B.
infantis displayed significant differences in the survival of those cells. Gene
expression analysis implicated that three host genes, BIRC3, TNFAIP3 and
SERPINB9 were induced in the host cells and likely the cause of the impact to
cell survival seen in the cytotoxicity assay. The mechanism by which these genes
were induced was predicted, tested, and proved. Adhesion to host cell
gangliosides results in a signaling cascade initiated by unknown GPCRs at the
cell surface resulted in the complete activation of AKT and subsequent increased
expression of the genes and translation of these survival proteins.
Impact of Work
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For the first time, a set of experiments has been conducted that will
allow researchers to better assess the properties of bacteria that qualify them as
a probiotic. Additionally, a model by which other bacterial species can be tested
for their beneficial properties has been established that removes a great degree
of complications that arise from animal or human subject systems. While these
more advanced models still have a place in this field, I posit that it is a great
benefit to gain insights and direction in a reduced variable system before
engaging in a complicated and expensive adult animal model.
The next point that should be addressed is that it appears that the word
commensal simply does not completely characterize the actual mode of
interaction between host and non-pathogenic microbe. B. infantis was first placed
in this group of neutral organisms, when clearly it is not a neutral organism (Fig.
16). This work furthers the notion that the bacteria residing in the human gut are
either doing our bodies some harm, or are doing them some good. While the
pathogens have received the bulk of the scientific attention through the centuries,
these commensals, if studied more in depth, may prove to not be merely sharing
our table, but actively participating in the preservation of the host in which they
reside.
Future Work
Identification of the host receptor that is bound by B. infantis should be the
focus of future work (Fig. 16). While these data suggested that GPR20 and
GPR161 were likely involved in binding, the adhesion assay performed to assess
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that showed otherwise. The role of these two receptors in the host response
should also be evaluated. As this study identified a cell-signaling pathway that
was activated by the presence of B. infantis what other signaling pathways are
active due to the presence of these two cell surface receptors? What impact, if
any, do those pathways have on the health of the host? Answering these
questions would bring valuable information to the field and

FIG. 16. Additions to field resulting from current study
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further clarify the relationship between host and probiotic.
In summary, B. infantis adhesion to host cells lead to increased cell
survival via cell signaling initiated by g-protein coupled receptors, through
complete activation of AKT, and culminating in the translation of three proteins
with described impacts on cell survival
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Appendix A. TABLE A.1. Complete list of significantly differentially expressed
host genes following adhesion of B. infanits
Symbol
CCL20

CXCL1
CXCL2
CXCL3
IL6
IL8

AGPAT4
ARL5B
BIRC3
CES4
CYP1A1
CYP1B1

DLST

G3BP1

Annotation
chemokine (C-C motif)
ligand 20
chemokine (C-X-C motif)
ligand 1 (melanoma growth
stimulating activity, alpha)
chemokine (C-X-C motif)
ligand 2
chemokine (C-X-C motif)
ligand 3
interleukin 6 (interferon,
beta 2)
interleukin 8
1-acylglycerol-3phosphate Oacyltransferase 4
(lysophosphatidic acid
acyltransferase, delta)
ADP-ribosylation factorlike 5B
baculoviral IAP repeatcontaining 3
carboxylesterase 4-like
cytochrome P450, family
1, subfamily A, polypeptide
1
cytochrome P450, family
1, subfamily B, polypeptide
1
dihydrolipoamide Ssuccinyltransferase (E2
component of 2-oxoglutarate complex)
GTPase activating protein
(SH3 domain) binding
protein 1

Type(s)

Log
Ratio

cytokine

-0.32

cytokine

0.079

cytokine

-0.402

cytokine

-0.015

cytokine

-0.234

cytokine

0.062

Cytoplasm

enzyme

-0.406

unknown

enzyme

-0.369

Cytoplasm
Cytoplasm

enzyme
enzyme

-0.243
-0.634

Cytoplasm

enzyme

-0.34

Cytoplasm

enzyme

-0.274

Cytoplasm

enzyme

-0.616

Nucleus

enzyme

0.489

Location
Extracellular
Space
Extracellular
Space
Extracellular
Space
Extracellular
Space
Extracellular
Space
Extracellular
Space

100

Symbol

GEM

HMGCS1
LYZ
MAGT1

Annotation
GTP binding protein
overexpressed in skeletal
muscle
3-hydroxy-3methylglutaryl-Coenzyme
A synthase 1 (soluble)
lysozyme (renal
amyloidosis)

Location

Type(s)

Log
Ratio

Plasma
Membrane

enzyme

0.215

Cytoplasm
Extracellular
Space
Extracellular
Space

enzyme

-0.215

enzyme

-0.888

enzyme

-1.112

Cytoplasm

enzyme

-0.527

Cytoplasm

enzyme

-0.847

Cytoplasm

enzyme

-1.12

Cytoplasm
Plasma
Membrane
Plasma
Membrane
Cytoplasm

enzyme

-0.68

enzyme

-1.24

enzyme
enzyme

-0.062
-0.171

Cytoplasm
Cytoplasm

enzyme
enzyme

-0.887
-3.026

Cytoplasm
Cytoplasm

enzyme
enzyme

-1.274
-1.496

Cytoplasm

enzyme
Gprotein
coupled
receptor
Gprotein
coupled

-0.342

UGCG

magnesium transporter 1
microsomal glutathione Stransferase 1
optic atrophy 1 (autosomal
dominant)
RAB2A, member RAS
oncogene family
RAB9A, member RAS
oncogene family
Ras homolog enriched in
brain
ras homolog gene family,
member V
Rho family GTPase 1
stearoyl-CoA desaturase
(delta-9-desaturase)
sialic acid acetylesterase
superoxide dismutase 2,
mitochondrial
thioredoxin
UDP-glucose ceramide
glucosyltransferase

GPR109
B

G protein-coupled receptor Plasma
109B
Membrane

GPR161

G protein-coupled receptor Plasma
161
Membrane

MGST1
OPA1
RAB2A
RAB9A
RHEB
RHOV
RND1
SCD
SIAE
SOD2
TXN

-0.224

-0.61
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receptor

Symbol

Annotation

Location

G protein-coupled receptor Plasma
20
Membrane
Extracellular
Space
AREG
amphiregulin
Extracellular
EREG
epiregulin
Space
jagged 1 (Alagille
Extracellular
JAG1
syndrome)
Space
LATS, large tumor
suppressor, homolog 2
LATS2
(Drosophila)
Nucleus
mitogen-activated protein
MAP3K7 kinase kinase kinase 7
Cytoplasm
mitogen-activated protein
kinase
kinase kinase 8
MAP3K8
Cytoplasm
NUAK family, SNF1-like
kinase, 2
NUAK2
unknown
nuclear casein kinase and
cyclin-dependent kinase
NUCKS1 substrate 1
Nucleus
phosphoenolpyruvate
carboxykinase 1 (soluble)
PCK1
Cytoplasm
pyruvate dehydrogenase
kinase, isozyme 4
PDK4
Cytoplasm
PIM1
pim-1 oncogene
Cytoplasm
RIOK1
RIO kinase 1 (yeast)
unknown
serine/threonine/tyrosine
kinase 1
STYK1
Cytoplasm
GPR20

NR4A1

nuclear receptor subfamily
4, group A, member 1

Nucleus

Type(s)
Gprotein
coupled
receptor
growth
factor
growth
factor
growth
factor

Log
Ratio

-0.485
0.334
0.347
-0.488

kinase

0.016

kinase

-0.308

kinase

-0.764

kinase

0.177

kinase

-1.993

kinase

0.344

kinase
kinase
kinase

0.004
-0.03
-0.479

kinase
liganddepende
nt
nuclear
receptor

-0.831

0.707
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Symbol

Annotation

Location

NR4A2

nuclear receptor subfamily
4, group A, member 2

Nucleus

NR4A3

nuclear receptor subfamily
4, group A, member 3

Nucleus

APP
AREGB
BRP44L

nuclear receptor subfamily
4, group A, member 3
activated leukocyte cell
adhesion molecule
amyloid beta (A4)
precursor protein
amphiregulin B
brain protein 44-like

Nucleus
Plasma
Membrane
Plasma
Membrane
unknown
Cytoplasm

C10ORF
110

chromosome 10 open
reading frame 110

C11ORF
1

NR4A3
ALCAM

Type(s)
liganddepende
nt
nuclear
receptor
liganddepende
nt
nuclear
receptor
liganddepende
nt
nuclear
receptor

Log
Ratio

-0.125

0.156

-0.01

other

-0.613

other
other
other

-0.122
0.029
-0.272

unknown

other

-0.721

chromosome 11 open
reading frame 1

Nucleus

other

-1.343

C17ORF
69

chromosome 17 open
reading frame 69

unknown

other

-0.225

C2ORF5
6

chromosome 2 open
reading frame 56

unknown

other

-0.836

C6ORF6
2
CALD1
CALD1

chromosome 6 open
reading frame 62
caldesmon 1
caldesmon 1

unknown
Cytoplasm
Cytoplasm

other
other
other

-1.095
-0.389
-0.179

CALD1

caldesmon 1

Cytoplasm

other

Symbol

Annotation
caspase recruitment
domain family, member 10
cyclin I
cyclin L1

Location

Type(s)

103
-0.544
Log
Ratio

Cytoplasm
unknown
Nucleus
Plasma
Membrane

other
other
other

-0.413
-0.621
-0.446

other

-0.079

Cytoplasm

other

-0.212

Cytoplasm
Extracellular
Space
Extracellular
Space
Extracellular
Space

other

-1.19

other

0.245

other

-0.115

other

0.067

unknown

other

-0.545

Cytoplasm
Cytoplasm

other
other

0.088
-1.214

other

-1.065

other

0.342

other

-0.222

other

0.024

CARD10
CCNI
CCNL1
CD9

CD9 molecule
cell division cycle 37
homolog (S. cerevisiae)CDC37L1 like 1
chromatin modifying
CHMP4B protein 4B
COL1A2

DNAL1

collagen, type I, alpha 2
cysteine-rich, angiogenic
inducer, 61
cysteine-rich, angiogenic
inducer, 61
DDB1 and CUL4
associated factor 5
DNA-damage-inducible
transcript 4
deleted in liver cancer 1
dynein, axonemal, light
chain 1

DST

dystonin

EFNA1

ephrin-A1
epithelial membrane
protein 1

unknown
Plasma
Membrane
Plasma
Membrane
Plasma
Membrane

family with sequence
similarity 134, member B
F-box protein 45

unknown
unknown

other
other

-0.667
0.026

FCF1 small subunit (SSU)
processome component
homolog (S. cerevisiae)

unknown

other

-1.268

CYR61
CYR61
DCAF5
DDIT4
DLC1

EMP1
FAM134
B
FBXO45
FCF1
(includes
EG:5107
7)

104
Symbol

Annotation

Location

Type(s)

Log
Ratio

FLJ1035
7

hypothetical protein
FLJ10357

unknown

other

-0.22

FLJ3684
8

hypothetical LOC647115

unknown

other

-1.371

GADD45
A

growth arrest and DNAdamage-inducible, alpha

Nucleus

other

0.242

Cytoplasm

other

-0.072

unknown

other

-0.746

Cytoplasm

other

-0.244

unknown

other

-0.575

unknown

other

-1.756

Cytoplasm

other

-1.049

Cytoplasm

other

-1.22

Cytoplasm

other

-0.53

Cytoplasm

other

-0.573

unknown

other

-0.945

unknown

other

-0.308

unknown

other

0.185

unknown
Extracellular
Space

other

-0.713

other

-0.316

GADD45
B

growth arrest and DNAdamage-inducible, beta
GRAM domain containing
GRAMD2 2
hyaluronan binding protein
4
HABP4
HERV-H LTR-associating
2
HHLA2
histidine triad nucleotide
binding protein 3
HINT3
hook homolog 1
(Drosophila)
HOOK1
heat shock protein 90kDa
HSP90B1 beta (Grp94), member 1
heat shock 70kDa protein
HSPA4L 4-like
immediate early response
IER3
3
immediate early response
IER3IP1 3 interacting protein 1
immediate early response
IER5
5
immediate early response
IER5L
5-like
inositol polyphosphate-5INPP5F
phosphatase F
ISG15 ubiquitin-like
modifier
ISG15

105

Symbol

Annotation
inositol 1,4,5-triphosphate
receptor interacting
ITPRIPL2 protein-like 2

Location

Type(s)

Log
Ratio

unknown

other

-0.947

KLHDC7
A

kelch domain containing
7A

unknown

other

0.2

LOC1001
28893

hypothetical protein
LOC100128893

unknown

other

0.201

LOC1001
30360

hypothetical
LOC100130360

unknown

other

-0.11

LOC1002
92959

similar to hCG2042049

unknown

other

-0.997

LOC2844
54

hypothetical protein
LOC284454

unknown

other

0.203

LOC2856
28

hypothetical protein
LOC285628
LON peptidase N-terminal
domain and ring finger 3
mex-3 homolog A (C.
elegans)

unknown

other

-0.078

unknown

other

-0.456

unknown

other

-0.283

unknown

other

-0.755

Nucleus

other

-0.903

Cytoplasm
Cytoplasm
Cytoplasm

other
other
other

-0.211
-0.49
-0.017

LONRF3
MEX3A
MGC162
75

MLLT4

NFKBIA
PDLIM3
PDLIM3

hypothetical protein
MGC16275
myeloid/lymphoid or
mixed-lineage leukemia
(trithorax homolog,
Drosophila); translocated
to, 4
nuclear factor of kappa
light polypeptide gene
enhancer in B-cells
inhibitor, alpha
PDZ and LIM domain 3
PDZ and LIM domain 3

106
PEAR1
Symbol
PER1
PLIN2

PSME4
RGMA
RP51022P6.2
RPL27A
RPL38
(includes
EG:6169)
RPS11
RTN4
S100P
SERPINB
9

SNCA
SOCS3
SPATA2L

SPATS2L

SPATS2L

platelet endothelial
aggregation receptor 1
Annotation
period homolog 1
(Drosophila)
perilipin 2
proteasome (prosome,
macropain) activator
subunit 4
RGM domain family,
member A
hypothetical protein
KIAA1434
ribosomal protein L27a

ribosomal protein L38
ribosomal protein S11
reticulon 4
S100 calcium binding
protein P
serpin peptidase inhibitor,
clade B (ovalbumin),
member 9
synuclein, alpha (non A4
component of amyloid
precursor)
suppressor of cytokine
signaling 3
spermatogenesis
associated 2-like
spermatogenesis
associated, serine-rich 2like
spermatogenesis
associated, serine-rich 2like

unknown

other

Location

Type(s)

-0.408
Log
Ratio

Nucleus
Plasma
Membrane

other

0.319

other

-0.366

unknown
Plasma
Membrane

other

-0.012

other

-0.395

unknown
Nucleus

other
other

-0.061
-1.232

Cytoplasm
Cytoplasm
Cytoplasm

other
other
other

-1.016
-0.828
-0.226

Cytoplasm

other

-0.512

Cytoplasm

other

-0.851

Cytoplasm

other

-0.728

Cytoplasm

other

0.044

unknown

other

-0.793

unknown

other

0.121

unknown

other

0.117
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SPON1
SPRED1

Symbol

spondin 1, extracellular
matrix protein
sprouty-related, EVH1
domain containing 1

Extracellular
Space
Plasma
Membrane

other

-0.627

other

-0.054

Type(s)

Log
Ratio

other
other

-0.754
-0.629

other

-0.122

other

-0.517

unknown
Plasma
Membrane
Plasma
Membrane

other

-0.852

other

-0.314

other

-0.137

Cytoplasm

other

-0.293

Nucleus

other

0.152

Nucleus
Cytoplasm

other
other

0.065
-0.64

unknown

other

-0.367

Nucleus
Nucleus

other
other

-0.346
-0.312

Extracellular
Space

peptidas
e

-0.173

TM4SF1

Annotation
Location
synovial sarcoma, X
breakpoint 2 interacting
Plasma
protein
Membrane
transgelin
Cytoplasm
TCDD-inducible poly(ADPribose) polymerase
unknown
transmembrane 4 L six
Plasma
family member 1
Membrane

TMEM20
6

transmembrane protein
206

TMEM49

transmembrane protein 49

SSX2IP
TAGLN
TIPARP

TMEM49

transmembrane protein 49
transmembrane and
tetratricopeptide repeat
TMTC2
containing 2
tumor necrosis factor,
TNFAIP3 alpha-induced protein 3
tumor necrosis factor,
TNFAIP3 alpha-induced protein 3
TPM3
tropomyosin 3
TRAF3IP
3
WHSC1
ZNF295

TRAF3 interacting protein
3
Wolf-Hirschhorn syndrome
candidate 1
zinc finger protein 295

PLAU

plasminogen activator,
urokinase

108

SPG7

proteasome (prosome,
macropain) subunit, beta
type, 4
spastic paraplegia 7 (pure
and complicated autosomal
recessive)

Symbol

Annotation

PSMB4

PPP3CC

dual specificity
phosphatase 4
protein phosphatase 3
(formerly 2B), catalytic
subunit, gamma isoform

ATF3

activating transcription
factor 3

ATF3

activating transcription
factor 3

DUSP4

BHLHE4
0

BTG2

CEBPD

CREM

CREM

basic helix-loop-helix
family, member e40

BTG family, member 2
CCAAT/enhancer binding
protein (C/EBP), delta
cAMP responsive element
modulator
cAMP responsive element
modulator

Cytoplasm

peptidas
e

Cytoplasm

peptidas
e

Location

Type(s)

-0.688
Log
Ratio

Nucleus

phosphat
ase

-0.105

unknown

phosphat
ase

-0.503

Nucleus

transcript
ion
regulator

-0.298

Nucleus

transcript
ion
regulator

-0.063

Nucleus

transcript
ion
regulator

0.49

Nucleus

transcript
ion
regulator

-0.062

Nucleus

transcript
ion
regulator

0.037

Nucleus

transcript
ion
regulator

-0.01

Nucleus

transcript
ion
regulator

-0.231

-0.676
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CREM

cAMP responsive element
modulator

Nucleus

transcript
ion
regulator

-0.514

CREM

cAMP responsive element
modulator

Nucleus

transcript
ion
regulator

Symbol

Annotation

Location

Type(s)

-0.353
Log
Ratio

Nucleus

transcript
ion
regulator

-0.212

Nucleus

transcript
ion
regulator

-0.461

Nucleus

transcript
ion
regulator

-0.336

Nucleus

transcript
ion
regulator

-0.004

Nucleus

transcript
ion
regulator

0.286

Nucleus

transcript
ion
regulator

0.278

Nucleus

transcript
ion
regulator

0.381

Nucleus

transcript
ion
regulator

-0.1

Nucleus

transcript

-0.842

cysteine-serine-rich
CSRNP1 nuclear protein 1

CYLD

DLX1

cylindromatosis (turban
tumor syndrome)

distal-less homeobox 1

EGR3

early growth response 3

ELF3

E74-like factor 3 (ets
domain transcription factor,
epithelial-specific )

ELF3

E74-like factor 3 (ets
domain transcription factor,
epithelial-specific )

ELF3

E74-like factor 3 (ets
domain transcription factor,
epithelial-specific )

ETS2
GRLF1

v-ets erythroblastosis virus
E26 oncogene homolog 2
(avian)
glucocorticoid receptor
DNA binding factor 1

110
ion
regulator

HEY1

Symbol

HOXA2

hairy/enhancer-of-split
related with YRPW motif 1

Annotation

homeobox A2

HOXA2

homeobox A2

IRF1

interferon regulatory factor
1

IRF8

JUN

JUNB

KLF6

KLF7
LMCD1

interferon regulatory factor
8

jun oncogene

jun B proto-oncogene

Kruppel-like factor 6
Kruppel-like factor 7
(ubiquitous)
LIM and cysteine-rich
domains 1

transcript
ion
regulator

-0.23

Location

Type(s)

Log
Ratio

Nucleus

transcript
ion
regulator

0.193

Nucleus

transcript
ion
regulator

-0.101

Nucleus

transcript
ion
regulator

-0.236

Nucleus

transcript
ion
regulator

-0.34
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transcript
ion
regulator

0.713

Nucleus

transcript
ion
regulator

-0.316
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transcript
ion
regulator

-0.113

Nucleus

transcript
ion
regulator

-0.401

Cytoplasm

transcript

-0.463

Nucleus

111
ion
regulator

LMCD1

LIM and cysteine-rich
domains 1

Cytoplasm

transcript
ion
regulator

Symbol

Annotation

Location

Type(s)

LMO1

LIM domain only 1
(rhombotin 1)

Nucleus

transcript
ion
regulator

-0.456

MAFF

v-maf musculoaponeurotic
fibrosarcoma oncogene
homolog F (avian)

Nucleus

transcript
ion
regulator

0.26

MAFF

v-maf musculoaponeurotic
fibrosarcoma oncogene
homolog F (avian)

Nucleus

transcript
ion
regulator

-0.419

Nucleus

transcript
ion
regulator

-0.341

Nucleus

transcript
ion
regulator

0.182

Nucleus

transcript
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regulator

0.415

Nucleus

transcript
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regulator

-0.357

Nucleus

transcript
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regulator

-0.454

Nucleus

transcript
ion
regulator

0.539

MBD2

NFIL3

NFKB2

NFKBIE

NFKBIZ

NFKBIZ

methyl-CpG binding
domain protein 2
nuclear factor, interleukin
3 regulated
nuclear factor of kappa
light polypeptide gene
enhancer in B-cells 2
(p49/p100)
nuclear factor of kappa
light polypeptide gene
enhancer in B-cells
inhibitor, epsilon
nuclear factor of kappa
light polypeptide gene
enhancer in B-cells
inhibitor, zeta
nuclear factor of kappa
light polypeptide gene
enhancer in B-cells
inhibitor, zeta

-0.02
Log
Ratio

112

RCAN1

regulator of calcineurin 1

Nucleus

transcript
ion
regulator

Symbol

Annotation

Location

Type(s)

Nucleus

transcript
ion
regulator

-0.919

Nucleus

transcript
ion
regulator

0.012

Nucleus

transcript
ion
regulator

-0.49

Cytoplasm

transcript
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regulator

-0.051

Nucleus

transcript
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0.325
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transcript
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-1.554
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transcript
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-0.434

Nucleus

transcript
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-0.234

Nucleus

transcript
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-0.796

RCAN1

regulator of calcineurin 1

REL

v-rel reticuloendotheliosis
viral oncogene homolog
(avian)

SCML1
(includes
EG:6322)

sex comb on midleg-like 1
(Drosophila)

SERTAD
2

SERTA domain containing
2

SOX7

SRY (sex determining
region Y)-box 7

SPEN

spen homolog,
transcriptional regulator
(Drosophila)

TLE1

transducin-like enhancer
of split 1 (E(sp1) homolog,
Drosophila)

TSC22 domain family,
TSC22D1 member 1

ZNF397

zinc finger protein 397

0.108
Log
Ratio
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ZNF689

zinc finger protein 689

Nucleus

transcript
ion
regulator

Symbol

Annotation

Location

Type(s)

EEF1D

eukaryotic translation
elongation factor 1 delta
(guanine nucleotide
exchange protein)

Cytoplasm

translatio
n
regulator

-1.006

EIF5B

eukaryotic translation
initiation factor 5B

Cytoplasm

translatio
n
regulator

-0.945

albumin

Extracellular
Space

transport
er

-1.771

Cytoplasm

transport
er

-0.598

Cytoplasm

transport
er

-1.295

Cytoplasm

transport
er

-1.28

Cytoplasm

transport
er

-0.865

-0.179
0.027

ALB

adaptor-related protein
complex 2, beta 1 subunit
ATPase, H+ transporting,
ATP6V0E lysosomal 9kDa, V0
1
subunit e1
AP2B1

FABP1

fatty acid binding protein
1, liver

GLTP

glycolipid transfer protein

SLC25A2
5

solute carrier family 25
(mitochondrial carrier;
phosphate carrier),
member 25

Cytoplasm

transport
er

VPS13A

vacuolar protein sorting 13
homolog A (S. cerevisiae)

Cytoplasm

transport
er

-0.042

Log
Ratio
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APPENDIX B. GO Trees

FIG. B.1. GO Tree of Molecular Function
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FIG. B.3. GO Tree of Cellular Component
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APPENDIX C. GPCR Protein Analsysis
A)

FIGS. C.1.-C.2. GPR20 and GPR161 protein analysis
A) GPR161 transmembrane regions (http://bp.nuap.nagoya-u.ac.jp/sosui/cgibin/adv_sosui.cgi) and N-linked glycosylation sites
(http://www.cbs.dtu.dk/services/NetNGlyc/) as predicted based on sequence.
Red asterisks indicate predicted location of extra-cellular N-linked glycosylation
sites. Tan area indicates membrane of cell, while uppermost blue field represents
the extra-cellular space, with the lower blue field the intra-cellular space.
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B)

B) Similar plot as shown in A), for GPR20.
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Fig. B.2. GO tree of biological process
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